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ABSTRACT 
CHARACTERIZATION OF HUMAN COPPER/ZINC SUPEROXIDE DISMUTASE 
by Nada Khouderchah 
In this research, both human wild type (WT) and mutant A4V SOD1 were 
encapsulated in wet-aged sol-gel glasses in an attempt to identify intermediates leading to 
aggregation. The encapsulated proteins were subjected to various conditions known to 
cause aggregation in solution such as heat, low pH ~ 4.0, EDTA, TCEP or DTT, and 
TFE. Changes in the secondary structure of the entrapped SOD1 were monitored by 
using circular dichroism (CD) in the far-UV region. 
Results showed major differences between the WT and A4V SOD1 secondary 
structures under most conditions. The encapsulation method is shown to enable long-
term monitoring of the secondary structural changes over several months, and the optimal 
encapsulation method for the SOD1 is identified in order to minimize leaching. Finally, a 
possible common intermediate for both A4V and WT SOD1 was identified under 
different conditions. 
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CHAPTER 1 
1.0 Introduction 
1.1 Overview 
Amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease, is a 
progressive neurodegenerative disease that targets, and eventually destroys, the motor 
neurons in the spinal cord and brainstem (Bruijn et al., 2004). People of all races and 
ethnic backgrounds are affected. ALS cases are generally classified into two different 
groups: familial ALS (FALS), where a family history of the disease can be traced to a 
genetic defect, and sporadic ALS (SALS) (Rosen et al., 1993). FALS represents about 
5%-10% of the total number of ALS cases. In 20%-25% of FALS cases, the cause of the 
disease has been found to be associated with a genetic defect on chromosome 21 that 
codes for an important antioxidant enzyme called copper-zinc superoxide dismutase 
(CuZnSOD) (Bruijin et al., 2004; Valentine et al., 2005; Andersen et al, 2006). Even 
though this percentage is very small (l%-2.5% of the total number of ALS cases), 
understanding the mechanism by which the mutant SOD1 causes the disease may be a 
crucial step to unlocking the mystery of ALS in general. In fact, the common clinical 
symptoms of FALS and SALS suggest that the disease mechanism could also be common 
(Li et al., 1988). Thus, the effects of SOD1 mutations at the cellular and biological level 
may be relevant not only in FALS cases but in other ALS cases as well. 
The discovery of mutations in SOD1 that provided the first insight into the 
molecular basis of ALS was reported in 1993 (Rosen et al., 1993). To date, over 100 
different mutations have been identified and linked to ALS (http://www.alsod.org). 
Unfortunately, these mutations are widely scattered throughout the SOD1 structure, 
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which does not help in isolating a common denominator of the disease mechanism. 
Nevertheless, most of the evidence suggests that these mutations cause the 
neurodegenerative disease by adding a toxic function to the protein (Valentine et al., 
2005). This toxic property leads to an increased propensity for the pathogenic SOD1 to 
aggregate relative to the wild type (WT) protein (Ray et al., 2004; Meiering 2008) and to 
form amyloid-like fibrils (Bruijn et al., 2004). Aggregation usually occurs when a 
protein misfolds to a non-native conformation and fails to be degraded or to refold back 
to the native conformation. Consequently, the protein aggregate becomes the direct or 
indirect cause of the pathological conditions related to the disease (Dobson, 1999; Wang 
et al., 2008). Indeed, it was reported that the SOD1 mutants adopted different 
conformations than WT in vivo. These altered conformations of SOD1 mutants were 
observed prior to the formation of protein aggregates (Zhang and Zhu, 2006). Also, the 
crystal structures of two different mutants, A4V and II13T, showed large conformational 
changes as compared with the WT SOD1 in solutions (Hough et al., 2004). These results 
suggest that the conformational changes and the aggregate formation play an important 
role in the origin of the disease. Therefore, the detection and isolation of intermediates 
that could lead to aggregation are the obvious next steps. Our current knowledge of the 
pathogenic mechanisms of ALS is based mostly on studies with various mutant SOD Is in 
solution where the protein tends to aggregate with itself rather quickly (Valentine et al., 
2005; Banci et al., 2007; Cao et al., 2008). Thus, an alternate approach is needed to 
facilitate the detection of the intermediates leading to aggregation. 
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A summary of the latest literature related to this thesis is provided in this chapter, 
including the functions, structures, and findings of the protein SOD1 (WT and A4V 
mutant), as well as the sol-gel method of protein encapsulation. 
1.2 Overview of Experimental Goals 
The objective of this research is to detect possible intermediate(s) that could lead 
to protein aggregation by using the sol-gel encapsulation method. In this study, we 
encapsulate human SOD1 WT and mutant A4V proteins in silica glasses where every 
protein molecule is isolated in an attempt to prevent protein aggregation while applying 
various conditions that normally lead to aggregation in solution. The conditions used 
were: lowering the pH to 3.5, using the metal chelator ethylenediaminetetraacetic acid 
(EDTA) (DiDonato et al., 2003), adding mild denaturants such as 2, 2, 2-trifiuoroethanol 
(TFE), using heat treatment (Stathopulos et al, 2003), or reducing the disulfide bond with 
either dithiothreitol (DTT) or Tris (2-carboxyethyl) phosphine hydrochloride (TCEP) 
(Tiwari and Hayward 2003; Arnesano et al., 2004). Also, the effect of the salt 
tetramethylammonium chloride N(CH3)4C1 on SOD1 was investigated. Circular 
dichroism (CD) was used to observe conformational changes in the secondary structure 
of the encapsulated proteins. 
1.3 Structure of the Protein 
The human enzyme CuZnSOD is a 32-kDa homodimer with ellipsoidal 
dimensions of about 30x40x70 A in size. SOD1 is a stable enzyme. It is resistant to 
proteolysis and to inactivation by chemical denaturants such as 4% sodium dodecyl 
3 
sulfate (SDS) and 10 M urea (Forman and Fridovich, 1973; Marklund et al, 1997). In 
addition, fully metallated SOD1 unfolds at a temperature above 80°C (Rodriguez et al., 
2002). The unusual stability of SOD1 is due to its structural properties, which consist of 
an eight-stranded P-barrel motif, binding sites for copper and zinc ions, an intrasubunit 
disulfide bond, hydrophobic interactions, and a network of hydrogen bonds (Valentine et 
al., 2005; Shaw and Valentine 2006). 
SOD1 is a dimeric protein. Each subunit contains 153 amino acid residues, an 
internal disulfide bond, one copper and one zinc ion (Parge et al., 1992) (see Figure 1). 
Figure 1. Crystal structure of metal bound human SOD1 (figure from PDB, ID 2C9V). 
Copper ions are shown as orange spheres, and zinc ions as blue spheres. 
The two subunits are held together by hydrophobic interactions (Lynch et al., 
2004). Each subunit is arranged in a Greek key P-barrel structure composed of eight 
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antiparallel P-strands joined by seven external loops. Loops I, II and V form connections 
between adjacent strands. Loop IV (residues 49-84) is involved in interactions between 
the two subunits and contains Cys57, the zinc binding domain and part of the active site 
cavity. Cys57 forms an internal disulfide bond with Cys146. Loop VII (residues 121-144) 
is the electrostatic loop that plays a role in substrate attraction. Loop VI (residues 102-
114) contributes to the stability of the enzyme. Specifically, Leu106 and Leu38 act to 
stabilize the opposite ends of the P-barrel fold and the dimer interface. Each amino acid 
points its side-chain into the core of the P-barrel and stabilizes the structure through 
hydrophobic interactions (DiDonato et al., 2003; Fujiwara et al., 2005). Loop VI together 
with loop III (residues 37-40) forms the Greek- key connection across the P-barrel (Parge 
et al., 1992) (see Figure 2). 
Figure 2. Schematic drawing of the SOD1 structure, as adapted from Parge et al., 1992. 
P-sheets are shown as open arrows and enumerated in chronological order using Arabic 
numbers. Loops are drawn as lines and numbered using Roman numerals. 
The H-bond network contributes to the protein stability. For instance, a network 
of hydrogen bonds stabilizes the P-barrel structure and forms bridges between the loops, 
metal binding sites and structural elements of the subunit. Asp124 in the electrostatic loop 
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is hydrogen bonded to the non-ligating nitrogens of the copper ligand His and the zinc 
ligand His71. Also, the carbonyl oxygen on Gly141 in the electrostatic loop is hydrogen 
bonded to the non-ligating nitrogen of copper ligand His120. Furthermore, the copper 
binding site is connected to both the electrostatic and the disulfide loops through 
hydrogen bonds between the non-ligating nitrogen of His , a copper ligand, and the 
carbonyl oxygen of Gly61, which is hydrogen bonded with the catalytically important 
Arg143. In turn, Arg143 is hydrogen bonded to the carbonyl oxygen of Cys57 positioned in 
the disulfide loop and compromises part of the dimer interface. Also, Cys57 is involved 
in the intrasubunit disulfide bond with Cys146 located in P-sheet 8. Moreover, part of P-
sheet 8 is hydrogen bonded to Gly114 and Arg115 in the Greek key loop VI (Parge et al., 
1992; Valentine et al., 2005). So as observed, the hydrogen bond network connects and 
stabilizes the monomer subunit of hSODl. Furthermore, the binding of metals as well as 
the formation of intrasubunit disulfide bond between Cys57 and Cys146 stabilize the dimer 
structure and shift the equilibrium from monomer to dimer species. 
1.3.1 Role of Metals 
Each subunit contains one copper and one zinc ion. While the copper is 
coordinated by four histidine ligands (His46, His48, His63 and His120) and one water 
f\(\ 71 &ft 
molecule, the zinc ion is coordinated by three histidine ligands (His , His and His ) 
and one Asp . The copper and zinc ions share an imidazolate ligand, His (Parge et al., 
1992) (see Figure 3). 
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The copper ion is solvent exposed, whereas the zinc ion is buried inside the (3-
barrel (Fridovich, 1975). The copper ion is responsible for the catalytic activity of the 
hSODl protein. The Zn2+ ion plays a role in stabilizing the structure, adding a positive 
charge (Band et al, 2003) and providing, in yeast and human, the correct structure for 
productive interaction with its copper chaperone (CCS) (Furukawa et al., 2004). This 
suggests that the zinc ion is inserted before the copper ion. At this time, the process of 
zinc binding and the source of zinc ion in vivo are still unknown (Banci et al., 2003). 
Once the copper ion is added, the disulfide bond formation between Cys57 and Cys 4 
follows, and dimerization occurs in the holo-SODl protein (holo refers to fully-
metallated SOD1 protein). 
Figure 3. Schematic drawing of the metal binding of hSODl in the oxidized form. The 
Cu2+ is coordinated to one water molecule, three histidines 46, 48 and 120, and shares 
94- 94-
an imidazolate ring histidine 63 with the Zn In addition, the Zn is coordinated to one 
aspartic acid and two histidines, 71 and 80. 
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In the absence of metals, SOD1 is in the immature, apoprotein state. The 
disulfide-reduced apo-form of SOD1 is considered to be the best substrate to enter into 
the mitochondria, but it is the form most prone to aggregation (Furukawa et al., 2004). In 
the apoprotein, loop IV, which is involved in the dimerization, and loop VII, the 
electrostatic loop, become highly disordered and flexible. Under these conditions the two 
p-sheets look like an "open clam", and the buried zinc site becomes solvent exposed. 
Subsequently, Zn2+ can be added to the immature, reduced form of the enzyme, restoring 
order to the two loops (Banci et al., 2003) and inducing the dimeric state (Arnesano et al., 
2004). Recent findings have shown that upon the addition of just one zinc ion to the 
homodimer, the two loops become ordered, and possible communication between the two 
subunits occurs through contact between the zinc loop and the dimer interface (Potter et 
al., 2007). However, if the "open clam" configuration should occur in the monomelic 
species, then the edge (3-strands 5 and 6 of one monomer could interact with the edge 
strands of another monomer, leading to nonproductive protein-protein interactions 
(Valentine and Hart, 2003) such as those observed in fibril formation in ALS patients 
(Stathopulos et al., 2003). It has been shown that the loss of metal ions in mutant SODls 
significantly decreases the thermodynamic stability of the enzyme and leads to a partial 
unfolding transition and possibly misfolding and aggregation of the apo-SODl 
(Stathopulos et al, 2003; Lynch et al., 2004; Banci et al, 2008). In the case of A4V apo-
SODl, hydrogen exchange monitored by mass spectroscopy showed that the mutant was 
destabilized at the dimer contact at residues 50-53 and throughout residues 21-53, which 
consist of p3, p4, loop II and III (Rodriguez et al., 2005; Shaw et al., 2006). These 
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findings were in line with the various reports indicating that A4V apo-SODl aggregated 
by perturbing the dimer interface (Khare et al., 2004; Rakhit et al., 2004; Ray et al., 
2004). Furthermore, differential scanning calorimetry (DSC) studies showed that A4V 
apo-SODl was considerable less stable than WT apo-SODl (Rodriguez et al., 2005). 
1.3.2 Role of the Cysteine Residues 
There are four cysteine residues in the hSODl proteins at positions 6, 57, 111 and 
146. Cys57 and Cys146 form an intracellular disulfide bond (Tiwari and Hayward, 2003). 
This bond is a rare feature for an intracellular protein located in a highly reducing 
environment such as the cytosol (Hwang et al., 1992). When the disulfide bond is 
formed, it causes a shift in the monomer-dimer equilibrium favoring the dimeric species. 
Also, it is kinetically stable and, together with the metal ions, contributes to the stability 
of the enzyme (Arnesano et al., 2004; Furukawa et al., 2004). Hence, when the bond 
between Cys57 and Cys is reduced, loop IV becomes disordered and destabilizes part of 
the p-barrel, the dimer interface and the zinc-binding site. This could lead to loss of 
dimerization as well as metal ions, followed by partial unfolding. Indeed, mutant 
proteins are more susceptible to disulfide reduction and monomerization than the wild-
type protein (Arnesano et al., 2004). Recently, it was suggested that Cys57 and Cys146 
might play a role in protein aggregation by forming intermolecular disulfide bonds (Deng 
et al., 2006). 
As for the other two-cysteine residues, Cys6 is located inside the P-barrel where it 
is solvent inaccessible and Cys111 is solvent exposed and positioned near the dimer 
9 
interface (Tiwari and Hayward, 2003). From aggregation studies, it was observed that 
these two cysteine residues most likely form bonds within the fibrous aggregate and 
increase the severity of aggregation (DiDonato et al., 2003; Banci et al., 2007) (Figure 4). 
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Figure 4. Crystal structure of human SOD1 (figure from PDB, ID 1SPD). The cysteines 
are represented in yellow, and the coordinated metals are shown in green for copper and 
gray for zinc. 
1.4 Function of the SOD1 Protein 
Cu/Zn SOD is an antioxidant enzyme found mainly in the cytosol, nucleus, and 
mitochondrial intermembrane space of eukaryotic cells and in the periplasmic space of 
bacteria (Valentine et al., 2005). This enzyme has been shown to play a protective role in 
cells against oxidative stress by catalyzing the disproportionation of superoxide anion 
into O2 and H2O2. This reaction occurs through the alternate reduction and oxidation of 
the active site copper ion. This catalysis is a two-step process (Fridovich, 1995): 
Reaction 1: 0 - 2 + Cu 2 + ZnSODl 0 2 + Cu + ZnSODl 
Reaction 2: 0 2 + 2H+ + Cu+ZnSODl H 2 0 2 + Cu 2 + ZnSODl 
Cu/ZnSODl 
Net reaction: 2 0 2 + 2H+ ~^-~~~~~~- 0 2 + H 2 0 2 
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In the oxidized form, Cu has irregular five-coordinate geometry, and in the 
reduced form its configuration assumes nearly trigonal planar three-coordination 
geometry. From the crystal structure of the reduced form, it was shown that Cu+ moves 
1.3 A away from His63, which becomes protonated, and releases the water ligand. Zn2+ 
has a tetrahedral geometry (Valentine et al., 2005). 
To reach the copper ion, the superoxide anion is guided electrostatically through a 
positively charged, narrow channel (Cudd and Fridovich, 1982). The active-site channel 
with its bound metal ions is formed between the electrostatic loop VII and loop IV (Parge 
et al., 1992). Both steps of the reaction occur with a diffusion-controlled rate constant of 
2 x 109 M" s" , and each reaction step is pH-independent over the range of 5- 9.5 (Klung-
Rothetal, 1973). 
1.5 Amyotrophic Lateral Sclerosis (ALS)- the Disease 
FALS-linked mutations have been found in every major structural element in the 
dimeric enzyme such as the P-barrel, loop regions, disulfide bond, copper and zinc 
binding sites and the dimer interface region (Cleveland and Rothstein, 2001). The 
majority of these mutations are point mutations in the DNA that cause amino acid 
substitutions, deletions, or insertions that lead to frameshifts and truncations (Valentine et 
al., 2005). ALS mutant SOD1 proteins fall into two categories depending on their metal 
content, SOD activity and spectroscopic characteristics. The first category is known as 
"wild type-like" (WTL) mutants for which the activity and spectroscopic characteristics 
of the mutant SOD1 are similar to those of wild-type (WT) SOD1. The second category 
is comprised of the "metal-binding-region" (MBR) mutants. MBR mutants contain lower 
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levels of metallation and exhibit different characteristics than the WT SOD1. These 
mutations are usually found in the metal binding ligands or in the electrostatic and zinc 
loop regions that are involved in metal binding (Valentine and Hart, 2003). Table 1 lists 
the 2 categories of FALS mutant SOD1 proteins (Valentine et al., 2005). Now, the 
puzzling question is how could all these mutations, regardless of type or location, cause 
the same disease in ALS patients? 
Table 1. Lists of FALS mutant SOD1 proteins as adapted from Valentine et al., 2005. 
The WTL mutants have biophysical characteristics that are close to WT SOD1 protein. 
The MBR mutants have different biophysical properties than WT SOD1 protein. 
Wild-type-like (WTL) mutants 
A4V ! G72S | G93V j N139K 
l_8C3 j L84V i E100K j L144S 
! ! i 
G37R | N86S | D101N j A145T 
I i ! 
L38V | D90A j D101G | V148G 
I ! I I I I 
G41D ! G93A I 11 l i t" 1 I149T 
G41S i G93R i R115G j 
H43R j G93C \ E133Del | 
1 ! t 
Metal-binding 
region (MBR) 
mutants 
H46R 
H48Q 
H80R 
G85R 
D124V 
D125H 
S134N 
C146R 
1.5.1 Gain of a Toxic Function 
At this point, it is generally accepted that SOD1 mutations result in a gain, rather 
than a loss, of some toxic function. These findings have provided support for this 
hypothesis. First, transgenic mice that expressed both the human FALS mutant G93A 
13 
SOD1 and their normal mouse WT SOD1 gene did develop progressive 
neurodegeneration despite having higher SOD activity. On the other hand, transgenic 
mice that expressed human WT SOD1 plus their normal mouse WT SOD1 gene did not 
exhibit ALS symptoms (Gurney et al., 1994), and the SOD1 knock-out mice did not 
develop motor neuron disease (Reaume et al., 1996). Also, in some FALS mutant SOD1, 
the enzymatic activity was not affected (Borchelt et al., 1994). 
Four major hypotheses have been proposed to explain the toxic gain of function: 
1) excitotoxic death due to mishandling of glutamate (Cleveland et al., 2000), 2) 
neurofilament disorganization leading to axonal strangulation (Hirano et al., 1984), 3) 
oligomerization (Kaytor and Warren, 1999; Watanabe et al., 2001; Julien, 2001), and 4) 
oxidative damage (Wiedau-Pazos et al., 1996; Roe et al., 2002). The last two hypotheses 
have been the main focus of studies of ALS mutant proteins (Rakhit at al., 2002; 
Valentine and Hart, 2003; Banci et al., 2008; Meiering 2008). The oligomerization 
hypothesis states that ALS mutant SOD1 proteins become misfolded, oligomerize into 
high molecular weight species, aggregate with other essential proteins and eventually 
become proteinaceous inclusions. It is possible that the intracellular aggregate proteins, 
at some point in their formation, become toxic to motor neurons and cause damage to 
cellular components and pathways (Valentine and Hart, 2003). Also, it is suggested that 
the accumulation of aggregated proteins cause oxidative damage. The oxidative damage 
hypothesis proposes that the misfolding of a mutant SOD1 protein modifies the 
enzymatic mechanism and allows the protein to catalyze reactions with hydrogen 
peroxide or peroxynitrite. In turn, reactive species of nitrogen and oxygen become toxic 
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by inflicting damage to proteins by alteration of amino acid side chains, fragmentation of 
polypeptide chains, and generation of covalent and noncovalent aggregation (Johnston et 
al., 2000). The oxidative damage hypothesis requires copper or some other redox active 
metal ion to be involved in the enzymatic activity. However, some evidence has 
challenged the validity of the oxidative hypothesis and suggests that the effect of SOD1 
mutations in FALS is a result of altered copper chemistry or SOD1 activity 
(Subramaniam et al., 2002). On the other hand, there is some evidence of damage in the 
tissues of ALS transgenic mice, caused by elevated oxidative stress (Valentine, 2002). 
For example, in the G93A mouse, it was found that the mutant CuZnSODl protein itself 
was heavily oxidized (Andrus et al, 1998). Also, oxidative stress may be linked to the 
accumulation of the unfolded or partially unfolded mutant SOD Is due to decreased 
proteasome activity and /or degradation of oxidatively damaged SOD1. This could 
overwhelm or impair the cellular chaperone capacity, cause mitochondria dysfunction, 
and disrupt other cellular processes (Tiwari and Hayward, 2003). Thus, the oxidative 
damage theory cannot be discarded. Nevertheless, in each hypothesis misfolding and 
aggregation are linked to toxicity, and the two hypotheses are most likely intertwined 
(Valentine and Hart, 2003; Rakhit et al., 2004; Banci et al, 2008) (see Figure. 5). 
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Figure 5. Diagram showing the possible steps of oligomerization and their connection 
to the oxidative damage hypothesis. 
1.5.2 Aggregation Studies 
The toxicity of mutant SOD1 could very well be the outcome of aggregation. 
Mounting evidence suggests that the aggregation propensity of mutant SOD1 may be the 
common denominator for all the different mutations (Lindberg et al., 2002; Khare et al., 
2004; Rakhit et al., 2004). Stathopulos and co-workers (2003) showed by using thermal 
studies of various mutant SOD Is that mutations decreased the protein stability and 
16 
increased the unfolding rate. This destabilization increased the propensity of mutants to 
aggregate (Wang et al., 2008). As indicated in aggregation studies performed in vitro, 
this process is a multistep reaction that consisted of dimer dissociation, apo-monomer 
formation followed by aggregation of the monomer species (Khare et al., 2004; Rakhit et 
al., 2004; Ray et al, 2004). This process is in equilibrium (Khare et al, 2004): 
Dholo <-» 2Mholo <-> 2Mapo —• A (Dholo = holo-dimer, Mholo = holo-monomer, 
Mapo = apo-monomer and A = aggregate). Evidence suggests that the dimer is not the 
reactive species in aggregation. Instead, the apo-monomer can be a possible intermediate 
in aggregation. Next, high molecular weight, insoluble protein complexes (IPCs) appear 
as an early event (Johnston et al., 2000). Then late in the disease, aggresomes or 
inclusion bodies are formed (Johnston et al., 2000). Inclusion bodies were found in the 
cytoplasm of motor neurons in ALS patients and transgenic mice expressing human 
FALS linked SOD1 transgene. SOD1 protein was detected in these inclusion bodies, 
(Johnston et al., 2000) along with ubiquitin and neurofilament proteins (Valentine and 
Hart, 2003). The inclusion bodies were associated with amyloid deposits, which were 
fibrils formed by |3- pleated sheets of the protein (Elam et al., 2003). 
1.5.3 Mutant Ala 4 Val (A4V) 
The A4V mutant is the most common FALS mutation in North America 
(Stathopulos et al., 2003). It is associated with the most rapid progression of the disease. 
The apo-A4V protein has a significantly decreased thermal stability compared to WT 
SOD1 (Rodriguez et al., 2002, 2005), and exhibits an increased susceptibility to disulfide 
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reduction (Tiwari and Hayward, 2003). At low protein concentrations, A4V favors the 
monomer species and aggregates spontaneously in solution at 37°C (Ray et al., 2004). 
This mutation disrupts the dimer interface, which is formed by reciprocal contacts 
between the C-terminal (3-strand 8 and residues from the disulfide loop (loop IV). The 
main dimer contacts are residues 50-53, 114, 148 and 150-153. Most of the dimer 
interface interactions in WT SOD1 are similar in the A4V structure, except at the 
mutation site and around the N-terminus. It is found that the structure of the metal sites is 
unaffected by the mutation (Hough et al., 2004), but significant structural changes occur 
from the increase in volume due to the two additional methyl groups in valine. As a 
consequence, some bond lengths change, while others are lost or added. Studies revealed 
that side chains of residues Phe20, Leu106, lie113, He149 and lie151, which are near Val4, 
shift in a concerted fashion due to steric constraints of the extra two methyl groups on 
valine and cause changes in the hydrophobic interactions (Cardoso et al., 2002; Hough et 
al., 2004). In WT SOD1, He has a close, single hydrophobic interaction with Ala with 
a bond length of 3.6 A. However in the A4V mutation, He113 moves away from Val4, 
loses the close interaction, and makes an additional bond. This change causes lie149 to 
shift closer to Val4, and in turn He151 rearranges its position (Hough et al., 2004). 
Moreover, the subtle change of Phe20 is associated with the rearrangement of the 
important Leu106 that protrudes from the P-barrel (Cardoso et al., 2002). These 
observations indicate that there are significant changes in the overall molecular 
conformation at the interface, which lead to a different orientation of the two monomers 
and to destabilization of the dimer interface. As a consequence of this destabilization, a 
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chain of steps would occur: 1) the monomer-dimer equilibrium would favor the monomer 
species, 2) subunits would have an increased tendency to lose metal and /or to unfold, 
(Cardoso et al., 2002; DiDonato et al., 2003; Hough et al., 2004) and 3) the apo-monomer 
species would be produced, as implicated in aggregation (Khare et al., 2004). When the 
dimer interface in A4V was stabilized with an engineered intrasubunit disulfide bond, 
monomerization and aggregation did not occur. Actually, the new A4V became as stable 
as WT (Ray et al., 2004). 
In conclusion, the observations presented here about the mutant A4V follow the 
general trend that could be a common theme for all or most FALS mutants SOD Is. 
Hence, using this mutant in this research might be a good model for detecting probable 
intermediate(s) that lead to aggregation. 
1.6 Sol-Gel Encapsulation of Proteins 
In this research, the sol-gel method is used to entrap the SOD1 in a nanoporous 
silica matrix. The advantages and disadvantages of this method are numerous, and the 
following list highlights only the relevant ones for this investigation. 
Advantages: 
• The sol-gel method may stabilize the encapsulated protein due to the 
excluded volume of the silica matrix (Eggers and Valentine, 2001a). The 
effects of the excluded volume on the protein's structure in vivo may play 
an important role since a large fraction of the available volume in a living 
cell is occupied by macromolecules (Minton, 2001). 
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• The sol-gel method allows protein contact with solvents for 
conformational studies while preventing protein aggregation. 
• Glass entrapment generally improves the thermal stability of proteins 
(Eggers and Valentine, 2001b). 
• The protein is encapsulated in a pore size small enough to prevent 
leaching of the biomolecule, but large enough to allow smaller analytes to 
enter the matrix. 
• The final material is optically transparent, which makes spectroscopic 
measurements possible (Eggers and Valentine, 2001a; Jin and Brennan, 
2002). 
• The bovine SOD1 molecule is known to retain its structural integrity and 
biological function in silica glasses (Ellerby et al., 1992). 
Disadvantages: 
• Possible leaching of the protein molecules out of the pores (Pierre, 2004). 
To overcome this problem, surfactants such as poly(ethylene oxide) could 
be added to control the pore size (Wei et al., 2002). In this work, protein 
leaching did occur, and that will be discussed in section 4.1.1. 
• The protein can be damaged possibly by the electrostatic interaction with 
the matrix (Pierre, 2004). Cox and co-workers (2003) used 
poly(ethyleneimine) to provide protection to the enzyme lactate oxidase. 
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• Due to the interference of the sol-gel materials in the far-UV, the CD 
spectra will be stopped at 200 nm. Any readings beyond the 200 nm 
become unreliable due to the high noise to signal ratio. 
In general, the sol-gel process involves the transition of a system from a liquid 
"sol," mostly colloidal, into a solid phase. The starting materials or precursors used in 
the preparation of the sol are usually inorganic metal salts or alkoxysilanes that may have 
a metal center or functional groups (Wright and Sommerdijk, 2001). Tetramethoxysilane 
(TMOS) is used in this study. A series of chemical reactions occurs that may proceed 
simultaneously, starting with hydrolysis, which can be acid or base catalyzed. Then the 
condensation and polycondensation reactions, which are responsible for building the SiCh 
cage surrounding each biological molecule. Next, gelation occurs such that the mixture 
does not pour out of the container if tipped. In this step, links form between silica sol 
particles to form a giant spanning cluster. After that, the aging process takes place where 
further condensation and polycondensation reactions happen, thus strengthening the 
matrix material. Also, during this phase the products of hydrolysis and condensation may 
evaporate, i.e., alcohol and water, causing the matrix and pores to shrink. Overall 
shrinkage of the material could be up to 85% of the initial volume (Jin and Brennan, 
2002; Pierre, 2004). A wet gel can be obtained or a xerogel may be formed by 
evaporation. Figure 6 shows the different stages of sol-gel processing. 
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Figure 6. Schematic drawing of the sol-gel steps adapted form Jin and Brennan, 2002. 
The process begins with hydrolysis, then condensation and polycondensation. Next, the 
biomolecules are added. Subsequently, gelation and aging occur. A wet gel or xerogel 
can be obtained, depending on the drying conditions. 
1.7 Circular Dichroism (CD) 
Circular dichroism (CD) spectroscopy is a form of light absorption spectroscopy 
that measures the difference in absorbance of right and left circularly polarized light by a 
molecule which exhibits absorbance and is structurally asymmetric. Asymmetry occurs 
when a molecule is chiral (non-superimposable on its mirror image), non-chiral but 
covalently attached to a chiral molecule such as aromatic amino acid side chains, or non-
chiral present in an asymmetric environment e.g., a chromophores bound to a protein 
(Hammes, 2005). CD is well suited to determine and monitor structural and 
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conformational changes in proteins. The near ultraviolet (UV) region (320-260 nm) 
provides information about the tertiary structure of the protein, and the far-UV region 
(260-190 nm) gives information regarding its secondary structure (Sreerama and Woody, 
2004). The different secondary structures of proteins are alpha helix, parallel and 
antiparallel beta sheet, and random coil. Analysis materials have been developed to 
characterize components of the secondary structures (Sreerama et al., 1999; Sreerama and 
Woody, 2000). CD data are reported in units of absorbance or ellipticity (G). Molar 
ellipticity ([0]) is normalized for concentration, and is usually expressed in (deg cm2/ 
dmol) (Sreerama and Woody, 2004). Before obtaining CD data, pure nitrogen is 
circulated in the instrument to purge any oxygen from the system, since oxygen absorbs 
light around 200 nm, and interferes with the measurements. 
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CHAPTER 2 
2.0 Materials and Methods 
2.1 Materials 
Tris-HCl, methanol, dithiothreitol (DTT), Cu sulfate and Zn sulfate 
heptahydrate were purchased from Sigma. Potassium acetate (KOAc) and HC1 were 
bought from Fisher Scientific. Tris (2-carboxyethyl) phosphine hydrochloride (TCEP-
HC1) was obtained from Hampton Research. Ethylenediaminetetraacetic acid (EDTA) 
was purchased from EMScience. Tetramethylorthosilicate 99+ % (TMOS), 
trimethoxypropylsilane 96% (propylTriMOS), and tetramethylammonium chloride 
(N(CH3)4C1 or TMAC1) were obtained from Aldrich. 2, 2, 2- trifluoroethanol (TFE) was 
purchased from Fluka. Plastic cassettes of 1.0 mm were bought from Invitrogen. 
Bovine SOD was purchased from OxisResearch. Human SOD was a generous gift from 
J. S. Valentine (UCLA) and P. J. Hart (UT Health Science Center, San Antonio). P. J. 
Hart donated the mutant A4V. Purified water (Milli Q) was used in all the experiments. 
2.2 Preparation of Solutions 
Tris buffer, 10 raM, at pH 8.0 and 7.0 were prepared. KOAc buffer at 5 mM, pH 
5.5, and at 10 mM, pH 5.7, 5.5 and 4.0 were made. Two different disulfide reducing 
agent solutions were prepared: one was 6 mM DTT at pH 5.5, and the other one 40 mM 
TCEP at pH 5.5. A salt solution of 1 M N(CH3)4C1 at pH 7.0 was prepared. 100 and 1 
mM EDTA were used in conjunction with 10 mM KOAc buffer at pH 4.0 for a final 
concentration of 10 and 0.33 mM EDTA respectively. Protein leaching out of the sol-gel 
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pores causing loss of the CD signal was a major problem in this work. To circumvent 
this issue, sol-gel samples were used immediately after the two weeks of maturation, and 
samples were kept at 4°C at all times (except during incubation periods at 37°C or during 
testing). As observed in Figure 30, most of the samples had enough protein to give a 
good CD signal even after 12 days of incubation (except for the sample incubated in 10 
mM Tris buffer at pH 8.0). 
A series of TFE solutions was prepared from 15-80% (vol/vol) at pH 5.4. A Zn2+ 
sulfate and Cu sulfate stock solution of 0.100 M concentration of each was made and 
then diluted with 5 mM KOAc buffer at pH 5.5 to obtain the desired concentration of 20 
mM Zn2+ and 20 mM Cu2+ at pH 5.5. 
Two different disulfide reducing agents, DTT and TCEP-HC1 were used because 
TCEP-HC1 has some advantages over DTT. TCEP-HC1 is odorless, resistant to air 
oxidation and is more stable and effective than DTT over a broad range of pH. TCEP-
HC1 reduces peptides and proteins over a wide range of pH (between 1.5-11.1), salt, 
detergent and temperature conditions. Also, TCEP-HC1 is unreactive toward other 
functional groups in proteins. Another useful property of TCEP-HC1 is the ability to 
dissolve in water resulting in a solution pH ~ 2.5, which could be adjusted to the desired 
experimental pH. TCEP-HC1 has about 80% of the reducing capacity intact for 21 days 
over a wide range of pH. TCEP-HC1 reduction is rapid when a molar excess is used with 
the sample. Furthermore, it can be used with IR and NMR spectroscopy 
(http://www.hampton research.com). 
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2.3 Standard Sol-gel Preparation 
Three 15-ml plastic tubes were used per batch. In each tube the following 
reagents were added in this order: 1.00 mL of TMOS, 30.0 uL of 0.040 N HC1 and 214 
uL of Milli Q water. The acid catalyst HC1 was added in this step with the precursor 
materials to speed up the hydrolysis reactions without denaturing the protein. Next, the 
solutions were mixed gently, and then placed in ultrasound sonicator filled with ice / 
water for 20 minutes. Afterward, 4.65 mL of aqueous protein / buffer solution was added 
to the hydrolysed TMOS mixture of 3.10 mL (determination of protein concentration and 
aqueous protein / buffer volume are covered in the next section). At this point the entire 
mixture had a volume of 7.75 mL. Next, the mixture was divided in half and 
immediately transferred using a plastic pipette into two plastic cassettes. When the 
mixtures were solidified, the cassettes were covered with parafilm and placed at 4°C for 
24 hours. The next day, the methanol-rich liquid that formed on top of the gel was 
drained, a few milliliters of Milli Q water were added, and the cassettes were covered 
again with parafilm. The sol-gel mixtures were placed back at 4°C for two weeks to 
mature (Ellerby et al., 1992; Eggers and Valentine, 2001a) (see Figure 7). 
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TMOS = 1.000 mL 
HC1 = 30 uL 
H20 = 214 uL 
Per tube = 1.244 mL 
Total = per tube x 3 
= 3.732 mL 
Original protein stock 
X mL original protein stock 
(4.65- X) mL buffer 
nil iiiliilBlVTillli-' " ' ~ 
3.732 mL 
(TMOS +HC1+H20) 
4.65 mL 
(protein + buffer) 
Use only 3.10 mL 
from this mixture 
Figure 7. A schematic drawing describing the standard sol-gel preparation. 
After two weeks of aging, the sol-gel sheets were ready to be prepared as 
individual samples for experiments. Each silica sheet was cut vertically about every 
centimeter with a razor blade to give multiple small wafers that fit into a quartz cuvette 
with a 2 mm pathlength, as used in CD analysis. Then, each silica wafer was incubated 
in 3.0 mL of the desired buffer or solution at 4 or 37°C for a minimum of 24 hours to 
assure the pore volume of the glass has fully equilibrated with the solution (Eggers and 
Valentine, 2001a). Next, samples were carefully moved to a cuvette using forceps and 
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immersed in their original buffer or solution (unless otherwise specified), and CD spectra 
in the far-UV were recorded using the circular dichroism spectrophotometer, AVIV 
Model 215. Data were collected from 200 to 260 nm at 25°C unless mentioned 
differently. One scan was taken for each sample with an averaging time of 1.0 second, 
and the blank control spectrum (buffer only) was subtracted from each scan. 
Also, a 10% propyl-modified wet sol-gel was prepared following the same 
procedure as above with one exception with the starting materials: 2.650 mL of TMOS 
was added to 0.350 mL of propylTriMOS. Then, 1.000 mL of TMOS/ propylTriMOS 
mix was added to each of the three 15-mL plastic tubes. The next steps were the same as 
the standard sol-gel preparation, procedure and testing given above. 
2.4 Protein Concentration 
Bovine Cu/Zn SOD (bSODl) was used in this research as a reference. The 
protein concentration and stock dilution needed for a good CD signal were determined 
using bSODl since its molecular weight and protein concentration were similar to the 
WT hSODl and A4V. A 1: 20 dilution of the original protein stock of 10 mg/ml (in 10 
mM Tris buffer, pH 7.0) was used since it produced a strong signal with little noise from 
the total absorbance. The concentration of bSODl was determined using the UV-Vis 
spectrophotometer and by applying the Beer-Lambert law: 
A = ex ex 1 
Where 
• A is the measured absorbance, 
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• 8 (L mol1 cm1) is the extinction coefficient at some characteristic wavelength, 
• 1 (cm) is the pathlength of the cuvette in which the sample is contained, 
• c (L/1 mol) is the concentration of the protein. 
The concentration is calculated as follows: 
c = (A x dilution factor x MW) / (s x 1) 
For the specific case of bSODl: 
• A = 0.143 (measured value obtained from the UV-Vis spectrophotometer), 
• e = 10,300 M"1 cm"1 at 258 nm (value obtained from Roe et al., 1998), 
• 1 = 0.200 cm, 
• dilution factor = 20, 
• MW = 32 500 g / mol (OxisResearch); is the molecular weight used to convert 
concentration to g / L. 
For the specific case of hSODl: 
• A = 0.498 (measured value obtained from the UV-Vis spectrophotometer), 
• 8 = 10,800 M"1 cm"1 at 280 nm (value obtained from Rodriguez et al, 2002), 
• 1 = 0.200 cm, 
• dilution factor = 20, 
• MW = 32 000 g / mol (Valentine et al., 2005). 
To determine how much protein to use in standard sol-gel samples, the following 
equation was employed: 
(Total volume of sol-gel 7.75 mL) / (20 dilution factor) = 0.39 mL. 
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The protein's volume was rounded to 0.40 mL. However, as the protein aged 
there was a need to increase the protein's volume to 0.60 mL (0.5 mg/ml or 15.6 uM) 
(1/40 is needed in a 2 mm cuvette path, and then 1/20 dilution will be used in a 1 mm 
thick glass, as determined by the cassette spacing). 
The aqueous protein / buffer solution must have a volume of 4.65 mL. So, if the 
protein's volume is 0.60 mL, then the buffer's volume (either Tris, pH 7.0 or KOAc, pH 
5.7) must be 4.05 mL by subtraction. 
2.5 Converting Raw CD Data to Mean Residue Ellipticity ([0]) 
Ellipticity values, 9, obtained from the CD instrument in units of mdeg were 
9 1 
converted to the mean residue molar ellipticity [0] in deg x cm x dmol" by using the 
following formula: 
[6] = (0 x MW x 100) / (NA x d x 1000 x CM) 
[0] = (0 x MW) / (NA x d x 10 x CM) 
Where: 
• 0 is the measured ellipticity (CD data in mdeg), 
• NA is the number of amino acids per protein (153 x 2) for dimer SOD1, 
• d is the path length in cm (0.1 cm for a glass sample), 
• CM is the molar protein concentration, 
o CM = (c x protein's volume used in sol-gel) / total volume of sol-gel, 
where c is the protein stock concentration obtained from the UV-Vis 
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instrument, the protein's volume used in sol-gel is 0.40 or 0.60 ml, and 
7.75 mL is the total volume of sol-gel. 
• Conversion factors: 
o 100 is used to convert the molar concentration to dmol x cm"3, 
o 1000 is used to convert millidegree to degree. 
2.6 Addition of Metals to hSODl and A4V 
94- 94-
Dilute stock metal solutions of Cu and Zn sulfate were added to ensure that 
the hSODl and A4V were fully metalated. The protein concentration [hSODl] was 
estimated as follow: Assume 10 g / L stock protein in 5mM KOAc, pH 5.5. [hSODl] = 
(10 g / L x 1000) / (32000 g/ mol) = 0.31 mM. The 1000 factor was used to convert 
molarity to a millimolar scale. Next, 30 uL of 20 mM Zn2+ sulfate was added to about 
10 g / L of stock solution of hSODl, and was incubated at 4°C for a few hours. Then, 
30 u.L of 20 mM Cu2+ sulfate was added to the protein stock solution and incubated at 
4°C for a minimum of 24 hours. Since Cu2+ has the tendency to occupy both the zinc and 
the copper binding sites, Cu2+ sulfate was added after the incubation with Zn2+ sulfate 
(Valentine et al, 1979). 
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CHAPTER 3 
3.0 Results 
3.1 First Aggregation Condition: Heat 
First, the CD spectra of WT SOD1 encapsulated in standard sol-gel was compared 
with that of WT in solution at 25°C to determine if any structural change occurred due to 
encapsulation. The reference spectrum shown in all of the figures in this document is the 
native conformation of encapsulated WT incubated in Tris buffer, pH 7.0, at 2°C. 
Similarly, for A4V figures, the reference used is that of the encapsulated A4V protein 
under like conditions. The reference of WT and A4V tests in solution is the native WT 
and A4V conformation in Tris buffer, pH 7.0, at 25°C. Based on the spectra shown in 
Figure 8A, the structural difference that could be attributed to encapsulation is minor 
(225-240 nm). While the sol-gel encapsulation process may trap proteins in non-native 
conformations as reported with hemoglobin (Khan et al., 2000) and apomyoglobin 
(Eggers and Valentine, 2001b), no such conformational changes were observed with WT 
orA4VSODl encapsulation. 
Next, the effects of heat treatment on the sol-gel encapsulated WT protein were 
compared with that of WT in solution. The spectra shown in Figures 8B-E are 
remarkably similar, and the major improvement in thermal stability, as reported 
previously for other proteins (Eggers and Valentine, 2001a), was not observed in this 
case. The secondary structure of the sol-gel encapsulated sample at 85°C (Figure 8F) 
appears to be more denatured than the solution structure at 85°C. This may be due to the 
fact that solution spectra were taken immediately upon reaching the desired temperature, 
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whereas sol-gel samples were equilibrated for about 5 minutes at each temperature before 
scanning. 
210 220 230 
Wavelength (nm) 
210 220 230 
Wavelength (nm) 
210 220 230 
Wavelength (nm) 
Figure 8. (A-I). Thermal denaturation of WT and A4V SOD1 at various temperatures. 
(A-F) CD spectra in the far-UV comparing WT SOD1 secondary structure in solution 
and in sol-gel at temperatures ranging from 25-85°C. The references shown for WT and 
A4V SOD1 are the spectra in solution without encapsulation, in Tris buffer, pH 7.0, at 
25°C. (G-I) CD spectra in the far-UV comparing A4V SOD1 secondary structure in 
solution and in sol-gel at 25, 37, and 85°C. 
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Finally, the effects of heat treatment on the secondary structures of sol-gel 
encapsulated WT and A4V proteins are compared (Figure 9). The structure of 
encapsulated A4V was found to be extremely sensitive to heat treatment as compared 
with WT. The encapsulated A4V sample began to denature at 37°C as compared to 75-
85°C for the WT (Figures 9B-C and 8G-I). In addition, the A4V sample denatured in 
two different structural conformations depending on the applied temperature range. From 
37-55°C, A4V conformational changes were different than those in the range of 
65- 85°C. The more negative molar ellipticity around 220-240 nm and 202 nm regions, 
and the positive trend around 210-215 nm region, suggests that a decreased p-structure 
and an increased random coil structure has transpired. Protein damage with heat 
treatment in the above range was irreversible for both the WT and A4V. The thermal 
stability of the A4V protein was not tested in solution since this mutant is known to 
aggregate (Ray et al., 2004). 
8-1 1 1 1 1 1 ^ 1 1 1 1 1 4 1 1 1 1 1 
200 210 220 230 240 250 200 210 220 230 240 250 200 210 220 230 240 250 
Wavelength (nm) Wavelength (nm) Wavelength (nm) 
Figure 9. Thermal denaturation of SOD 1. CD spectra of SOD 1 in the far-UV showing 
the effect of heat from 25-85°C on (A) WT in solution (B) encapsulated WT in sol-gel, 
and (C) encapsulated A4V in sol-gel. 
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3.2 Second Aggregation Condition: Low pH 
The effects of different low pH conditions (pH 4.0 and 5.7) on the secondary 
structure of the encapsulated WT and A4V proteins are examined in this section and 
compared to the structure at pH 7.0, which is used as a reference. 
3.2.1 Encapsulated WT and A4V Proteins in Tris Buffer, pH 7.0 
Initial expectations were that the encapsulated WT protein would be rather stable 
at pH 7.0. However, several drastic potential intermediate conformational changes were 
observed over the two-month test period, most of which occurred on the seventh and 11th 
day of the experiment (Figure 10A). The WT sample was stored at a constant 4°C during 
the entire test period, except when the CD measurements were taken at 25°C for short 
periods. A change in the secondary structure on the seventh day (Figure 10B) took place 
with a negative CD band at around 212 nm. In addition, this conformational change 
resulted in the loss of intensity of CD signal for all the tests that followed. This suggests 
that the unfolding/refolding process resulted in leaching of some of the encapsulated 
protein out of the sol-gel matrix. Furthermore, there is a strong evidence, as will be 
discussed in another section of this study, that the negatively charged protein at pH 7.0 
(pi ~ 5.8) is repelled by of the negatively charged sol-gel matrix. Moreover, leaching is 
dependent on the sol-gel pore size, which may differ for samples prepared with Tris pH 
7.0, and pH 5.7 (Hoang and Lee, 1997). Again, this will be discussed in more detail in 
Chapter 4, but it is mentioned here mainly to explain why this leaching did not occur with 
the A4V sample shown in Figure 10. Hence, in order to compensate for the lower protein 
concentration and facilitate comparison with the encapsulated A4V under similar 
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conditions, the CD data is normalized to have the same ellipticity value near the 
minimum. This is shown in Figures 10B-B' and a similar compensation is performed for 
the final measurement on the 54th day (Figures 10C-C). Based on the normalization 
factors used for the seventh and 54* day spectra, approximately 40% of the protein was 
lost after the seventh day, and an additional 10% was lost over the rest of the test period 
( l l l - 54l days). It is important to note that the odd measurement taken on the seventh 
day cannot be due to protein leaching out of the sol-gel matrix since the CD signal 
intensity on the ninth and 1 l l days are more negative in the 200-220 nm region (Figure 
10A). Thus, the CD data normalization shown in Figure 10-B' is performed mainly to 
highlight the remarkable similarity with the final A4V conformation in Figure 10E. 
Given that other odd measurements similar to the one observed on the seventh day are 
also noticed under different test conditions, this conformation could be a potential 
transient intermediate or simply an artifact. The possible causes are discussed in Chapter 
4. 
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Figure 10. CD spectra in the far-UV of encapsulated SOD1 incubated in Tris buffer, pH 
7.0. WT sample equilibrated (A) for 1, 2, 3, 7, 9, 11 and 54 days, (B) for 1, 2, 3, and 7 
days, (B') compensation for signal in day 7 as observed in A and B, (C) incubation after 
54 days and (C) compensation for signal in (C). (D) A4V sample equilibrated for 2, 4 
and 54 days, and (E) after 54 days. 
With the encapsulated A4V protein, a similar conformation to the one 
encountered with WT (seventh day) was observed, but the major difference is that the 
A4V protein did not refold to the native conformation even after 54 days (Figures 10B' 
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and E). In addition, the encapsulated A4V did not leach out of the sol-gel (i.e., no loss of 
signal was encountered) under identical test conditions used with WT except for the sol-
gel samples being prepared with slightly different methods (pH 7.0 vs. pH 5.7). This 
suggests that the A4V conformational changes were different as compared with the WT, 
but more importantly that these changes were irreversible. By comparing the spectra 
shown in Figures 10B'-C and Figure 10E, the final A4V conformational change was 
obviously more similar to the possible transient intermediate WT change that took place 
on the seventh day, as compared to the final WT conformation. The positive CD signal 
in the 225-235 nm region could be attributed to either disulfides or aromatic side chains 
(Sreerama and Woody, 2004). Even though aromatic side chains affect the CD signal 
significantly in the above region, especially for proteins with low a-helix content 
(Sreerama and Woody, 2004), it is suspected that the disulfide bonds are the major 
contributors in this case in spite of the fact that SOD1 protein has less than 7% a-helix 
content. This is based on other tests shown in section 3.4 that specifically target the 
disulfide bonds (i.e., addition of TCEP/DTT). It is important to note that the 
encapsulated A4V protein showed a significant dip in the 225-235 nm region (i.e., more 
negative ellipticity) in all of the other test conditions except for this one. This region 
(225-235 nm) was unaffected even after 54 days of incubation at pH 7.0, but the entire 
CD spectrum appeared to be slightly red-shifted as a result. Finally, this region was more 
positive for A4V SOD1 as compared with WT SOD1 in both solution and sol-gel 
encapsulated measurements. 
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3.2.2 Encapsulated WT and A4V Proteins in KOAc Buffer, pH 5.7 
The WT protein was encapsulated in two different standard sol-gel batches. In 
the first batch, KOAc buffer, pH 5.7, was used as the aqueous protein / buffer component 
during the sol-gel preparation, and in the second batch, Tris buffer at pH 7.0 was used. 
The protein stock and concentration used for both sol-gel batches was identical. 
From the first batch (prepared with pH 5.7 buffer), a WT sample was incubated in 
KOAc buffer, pH 5.7, for 54 days at 4°C, and CD measurements were taken periodically. 
Figures 11A-C show all the conformational changes observed with this sample. The 
most notable change in the secondary structure occurred on the third day, which indicates 
less content of P-structure (Hornemann and Glockshuber, 1998; Sreerama and Woody, 
2004; Fujiwara et al., 2005) with the characteristic 215 run signal intensity change 
(Figure 1 IB). On the seventh day the P-structure content becomes close to the native 
structure. After 54 days of incubation the conformation has a more negative value at the 
minimum near 209 ran than the native structure (Figure 11C). 
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Figure 11. CD spectra in the far-UV of encapsulated WT SOD1 in two different sol-gel 
batches. A sol-gel sample prepared with KOAc buffer, pH 5.7, incubated in KOAc, pH 
5.7, at 4°C is represented from (A-C); (A) incubation for 1, 2, 3, 7, 9, 11 and 54 days, 
(B) for 3, 7, 9 and (C) 54 days. A sol-gel sample prepared with Tris buffer, pH 7.0, 
incubated in KOAc, pH 5.7, at 4°C is described from (D-E); (D) incubation for 1, 2, 3, 
7, 9, 1 land 54 days, (E) for 7 and (F) 54 days. 
Surprisingly, the WT sample from the second batch (prepared with Tris, pH 7.0) 
demonstrated a completely different behavior under identical conditions (Figures 11D-F). 
None of the interesting potential transient intermediates that were observed with the other 
batch occurred with this sample. As will be discussed in Chapter 4, this is most likely 
due to the pore size difference of the sol-gel samples prepared with pH 7.0 and pH 5.7. 
Nonetheless, after 54 days of incubation, the change that occurred in the region between 
200-210 nm (Figure 1 IF) suggested that the metals might have been released. To test 
this hypothesis, additional measurements were conducted on the same sample, where Zn 
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and Cu ions were added (Figures 12A-B). While the addition of Zn ion caused a 
significant transformation in the secondary structure, the addition of Cu ion did not result 
in any changes in the conformation. Recently, Potter and co-workers reported similar 
results with the addition of Zn ion to the apoprotein in solution (Potter et al., 2007). After 
metal addition, the sample was placed back in KOAc, pH 5.7, for 28 days, and the final 
conformation that resulted was a near-native structure with a decrease in the negative 
ellipticity in the region between 205-215 nm (Figure 12C). Finally, the same sample was 
put in KOAc, pH 4.0, to destabilize the native fold (Chitin et al., 2002). After one day of 
incubation in pH 4.0 at 4°C, no major change was observed, but, after only 10 minutes of 
incubation at 37°C, a notable change in the 200-215 nm region was detected (Figures 
12D-E). The sample was then incubated at 37°C for longer periods resulting in a drastic 
change in the secondary structure (200-210 nm and 225-235 nm) (Figure 12F). This 
spectrum suggests that the protein's structure is largely unfolded at this stage. The dip in 
the 225-235 nm region is likely to be due to breaking the disulfides, to be discussed 
further in section 3.4. After another 20 days of incubation at 4°C in pH 4.0, the WT 
SOD1 appeared to regain structure, but the final conformation was a non-native structure 
(Figure 12G). It seems that the destabilization to the protein structure and the associated 
unfolding was partially reversible, unlike the temperature effects that were found to be 
irreversible. The WT SOD1 protein has shown an impressive tendency to fold and refold 
after partial unfolding under the effect of low pH at 37°C. This is in striking contrast to 
the A4V protein, as will be discussed in later sections. 
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Figure 12. CD spectra in the far-UV of encapsulated WT SOD1 under various 
conditions. (A) In KOAc, pH 5.7, for 54 days followed by Zn ion for 1 and 4 days, then 
Cu ion for one day, and then in KOAc, pH 5.7. (B) Addition of Zn ion for 4 days. (C) 
Incubation in KOAc, pH 5.7 for 28 days after the addition of Zn ion. (D) Equilibration 
in KOAc, pH 5.7, for 28 days was followed by incubation in KOAc, pH 4.0, for one day 
at 4°C, 10 minutes, and 3 days at 37°C, then 1 day at 4°C, another day at 37°C, and 20 
days at 4°C, (E) effect of KOAc, pH 4.0, at 37°C for 10 minutes, (F) in pH 4.0, for one 
day at 37°C, and (G) the final conformation after 20 days in KOAc, pH 4.0, at 4°C. 
Since none of the measurements that were observed with the second batch (sol-gel 
prepared with pH 7.0) showed the possible transient intermediates observed with the first 
batch (sol-gel prepared with pH 5.7), additional tests were conducted on the first batch 
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(pH 5.7). The same sample that was used previously (54 days in pH 5.7) was subjected to 
other conditions to see if the previously observed potential transients could be 
reproduced. The sample was first placed in Tris buffer, pH 7.0, and then changed to 40 
mM TCEP. No CD spectrum was obtained due to the magnitude of noise caused by the 
high absorbance of TCEP. Consequently, the sample was placed in Tris buffer, pH 7.0, 
for 2 days at 4°C, and then a measurable CD signal was obtained. The conformational 
changes that resulted are shown in Figures 13A-B. The change in the secondary structure 
(Figure 13B) is close to that observed on the third day with the original sample (Figure 
1 IB), however the protein leached out of the sol-gel matrix as shown in the following 
measurements (Figures 13C-D). In order to facilitate comparison with other 
measurements, the spectra were multiplied by a compensation factor as described 
previously to normalize the results (Figures 13C-D'). The final conformation indicates 
that the protein did fold back to the native conformation, and the dip in the range between 
200-208 nm is perhaps the result of releasing the metal in the process (by comparison to 
the apoprotein spectrum). EDTA was added at the end of this experiment but produced 
no further effects, suggesting that the metal had already been released in a previous step. 
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Figure 13. CD spectra in the far-UV of encapsulated WT SOD1 incubated in various 
buffers. (A) In KOAc at pH 5.7 for 54 days followed by Tris buffer, pH 7.0, after 1 day 
in TCEP, then another 6 days in Tris, pH 7.0, then placed back in KOAc, pH 5.7, for 2 
days, and finally in 30 mM EDTA for 6 days, (B) in Tris, pH 7.0, after 1 day in TCEP, 
(C) followed by Tris, pH 7.0, for 6 days, KOAc, pH 5.7, for 2 days, and in 30 mM 
EDTA for 6 days; (C) compensation for protein loss in (C), (D) CD WT protein in 30 
mM EDTA for 6 days and (D') compensation for protein loss in (D). 
Based on the results obtained with WT, A4V protein was encapsulated in the 
standard sol-gel made with KOAc buffer, pH 5.7. After one day of incubation at 4°C, 
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there was a noticeable difference in the starting point of the A4V spectrum relative to the 
solution spectrum with an increase in negative ellipticity between 220-250 nra as shown 
in Figures 14A-B. Another A4V sample was tested to confirm the change in the 
secondary structure, and the new sample produced identical results (Figures 14C-E). 
Then, Zn2+ was added to determine if the dip between the region 250-220 nm is related to 
metal loss (Figure 14D), but no major change was observed. It is important to note that 
no potential transient intermediates with P-characteristics were detected with the mutant 
A4V protein in pH 5.7 or 7.0, as previously was shown with the WT protein. 
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Figure 14. CD spectra in the far-UV of encapsulated A4V SOD1 incubated in various 
buffers at 4°C. (A) First sample equilibrated in KOAc, pH 5.7, for 1, 2, and 12 days and 
(B) 12 days. (C) A second sample equilibrated in KOAc, pH 5.7, for 2 and 12 days 
followed by the addition of Zn ion for 7 days, and then replaced with Tris pH 7.0 for 29 
days, (D) in KOAc, pH 5.7, for 12 days followed by the addition of Zn ions for 7 days, 
and (E) in Tris, pH 7.0, for 29 days. 
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3.2.3 Encapsulated WT and A4V Proteins in KOAc Buffer, pH 4.0 
This section focuses on the destabilization effect of low pH on the secondary 
structure of WT and A4V SOD1. Four WT samples were used; three of which where 
encapsulated in sol-gel made with KOAc, pH 5.7, and the fourth was encapsulated in sol-
gel made with Tris, pH 7.0. 
The first WT sample (sol-gel made with pH 5.7) was incubated in 10 mM KOAc 
buffer, pH 4.0, at 4°C for 54 days (Figures 15A-C). Most of the observed structural 
changes occurred in the 200-210 nm region, but none of the p-characteristics that were 
observed with pH 5.7 were encountered (Figures 1 IB and 13B). After 54 days, there was 
an increase in the negative ellipticity between 200-210 nm and a minor change in 228-
230 nm region indicating a slight destabilization of the protein. Since the secondary 
structure was stable at 4°C, a different approach was needed to perturb the structure and 
trap any intermediate conformations. 
The second WT sample (sol-gel made with pH 5.7) was initially incubated in pH 
4.0 at 37°C for 40 minutes to accelerate the destabilization, and then it was placed back at 
4°C (Figure 15D-F). After one day at 4°C, a significant change was detected in the CD 
spectrum in the region between 200-210 nm (Figure 15E), and the signal resembled the 
apoprotein spectrum in solution (Potter et al., 2007). Thus it was assumed that metal loss 
occurred. After four days, further changes were detected in the region between 200-210 
nm as well as 225-235 nm (Figure 15E). The sample was left in the same condition (at 
4°C) for six additional days, and the final conformation on the 10th day (Figure 15F) 
shows that the WT protein reverted to a conformation somewhat resembling the reference 
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except for the dip in the region between 200-210 nm. In addition, the recovery in the 
region between 228-230 nm was rarely observed with WT protein and never with the 
A4V mutant. 
The third WT sample (sol-gel made with pH 5.7) was incubated in KOAc, pH 4.0, 
at 37°C for multiple days. The protein adopted a random coil structure after just one day 
of incubation (Figure 15H). After four days, the structure unfolded completely (Figure 
151). Increasing the temperature from 4 to 37°C at pH 4.0 had a devastating effect on the 
stability and integrity of the WT structure. 
Finally, the fourth WT sample (sol-gel made with pH 7.0) was incubated in 
KOAc, pH 4.0, at 4°C for 7 days (Figures 15J-L). After seven-day incubation, the 
protein signal resembles the WT sample encapsulated in sol-gel made with pH 5.7 under 
identical test conditions (KOAc, pH 4, at 4°C). 
It may be worthwhile to note that with pH 4.0, no potential transient intermediates 
or folding/refolding of the protein were observed as compared with Tris, pH 7.0 and 
KOAc, pH 5.7. The main effect of lowering the pH to 4.0 is to destabilize the protein's 
native fold, which is a necessary process to begin aggregation (Chiti et al., 2002). This 
pH-induced unfolding is irreversible in the glass matrix if the temperature is raised to 
37°C. 
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Figure 15. CD spectra in the far-UV of encapsulated WT SOD1 incubated in KOAc, pH 
4.0. (A) The first sample was incubated at 4°C for 45 days, (B) day 1, 2 and 9 and (C) 
after 54 days. (D) The second sample was equilibrated in KOAc, pH 4.0, at 4°C for 10 
days after exposure to 37°C for 40 minutes, (E) after 1 and 4 and (F) 10 days. (G) The 
third sample in KOAc, pH 4.0, at 37°C for 4 days, (H) at day 1 and (I) 4. (J). The fourth 
sample in KOAc, pH 4.0, at 4°C for 7 days, (K) 1, 2 and (L) 7 days. 
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Two encapsulated A4V protein samples (sol-gel made with pH 5.7) were 
subjected to similar condition as the WT samples (10 mM KOAc buffer, pH 4.0, at 4 °C) 
for 28 and 20 days, respectively. The results were radically different than those observed 
with the WT samples. 
The first A4V sample was incubated at 4°C for a total of 28 days (Figures 16A-
C). After just one day of incubation, an increased negative ellipticity was observed in the 
spectrum region between 200-210 nm (Figure 16B). This change was more pronounced 
and slightly different than with the WT protein after two days at pH 4.0. Also, after two 
days of incubation, a drastic loss of the prominent ellipticity band at 230 nm was 
observed. This loss was common to the A4V protein under different aggregation 
conditions. Further unfolding continued after seven days, and then the structure became 
random coil after 28 days (Figure 16C). 
The second A4V sample was subjected to low pH as above, but at 37°C (Figures 
16 D-F). Initially the sample was incubated at 4°C for three days, which resulted in a 
similar destabilization as above. Consequently, the sample was subjected to heat 
treatment. After just 10 minutes at 37°C, there was a major impact on the secondary 
structure, and after 3 days at 37°C the protein was fully unfolded (Figure 16 E). The 
sample was then incubated for an additional 20 days at 4°C to see if the protein will 
attempt to refold, but the damage was irreversible (Figure 16 F). 
The data suggests that the mutant A4V is very susceptible to irreversible 
unfolding in an acidic environment even at a low temperature, 4°C. Therefore, the use of 
less harsh conditions such as pH 5.7 and 7.0 might be able to slow down the unfolding 
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process in an attempt to detect any possible intermediates that might have been missed at 
pH 4.0. 
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Figure 16. CD spectra in the far-UV of encapsulated A4V SOD1 incubated in KOAc, 
pH 4.0. (A) The first sample for 28 days at 4°C, (B) 1, 2, 7 and (C) 28 days. (D). The 
second sample was incubated at 4°C for 3 days, 10 minutes and 3 days at 37°C, 2 days 
at 4°C, 1 day at 37°C and 20 days at 4°C, (E) effect of temperature at 3 days at 4°C 
followed by 10 minutes and 3 days at 37°C and (F) 20 days at 4°C. 
3.3 Third Aggregation Condition: Removing Metals with EDTA 
Since apo-SODl has been implicated in aggregation studies performed in vitro, 
understanding the behavior and structural changes of the apoprotein or the conditions that 
might lead to metal loss could shed some light on its possible role in aggregation. To this 
end, both WT and A4V proteins were equilibrated in EDTA at 4 and 37°C. All samples 
incubated in 10 mM EDTA exhibited a very high ratio of noise to signal in the far-UV 
CD spectrum thus making analysis of the data impossible. To solve this problem, the 
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samples were washed with purified water and incubated in 10 mM Tris buffer at pH 7.0 
for about 30 minutes prior to testing in order to dilute the EDTA concentration and 
decrease the noise. This process does not affect the results because metal chelation by 
EDTA should have been complete after being equilibrated for 24 hours (Eggers and 
Valentine, 2001a). 
A sol-gel encapsulated WT sample made with KOAc, pH 5.7, exhibited a 
potential transient intermediate conformation at 215 nm after two days of incubation in 
10 mM EDTA, and then the protein reverted to the native conformation (Figures 17A-C). 
Interestingly, from the CD spectra there was no indication that an apoprotein was 
obtained during those three days, i.e., there was no detection of an increased negative 
ellipticity in the region between 200-207 nm. 
On the other hand, WT encapsulation in a sol-gel made with Tris, pH 7.0 did 
show possible metal loss (Figure 17E) after seven days in 10 mM EDTA. The CD 
spectrum showed an increased negative ellipticity in the region between 200-210 nm that 
suggested the formation of apoprotein. However, with the loss of metals, further 
destabilization of the native structure was expected to occur, but that was not the case. 
After 54 days, the CD signal resembled the reference with a near-native like 
conformation, but the signal in the 200-207 nm region was unusual (unlike native 
conformation or apoprotein). To determine if this was due to metal loss, Zn2+ was added 
after rinsing the glass to remove EDTA (Figures 17G-I). Even though, after the first day 
of adding Zn2+, there was an apparent change in the CD spectrum, after the fourth day 
there was no significant change from the initial condition. Cu2+ was added next, even 
51 
though there is no direct evidence implicating its role in the structural stability. Again, 
no change was detected (Figure 17G). It is possible that with this altered near-native 
conformation, the Zn2+ could not be added, or a permanent damage occurred in the zinc-
9+ 
binding site, or the Zn was added in a different region of the protein. Thus, the sample 
was placed back in EDTA and monitored for a long time (72 days) to determine which of 
the above possibilities is most likely. Given the lack of additional conformational 
changes (Figures 17H-I), the possibility of the zinc ion binding to a different location can 
be ruled out. 
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Figure 17. CD spectra in the far-UV of encapsulated WT SOD1 protein equilibrated in 
10 mM EDTA at 4°C. (A) The first sample at day 1, 2 and 3; (B) at day 2 and (C) day 3. 
(D) The second sample incubated for 54 days, (E) day 1, 2, 3, 7 and (F) 54; (G) after 54 
days in 10 mM EDTA, addition of Zn ion for 1 and 4 days, then Cu ion for 1 day, and 
then placed back in 10 mM EDTA for 72 days; (H) the addition of Zn ion for 1 and 4 
days after incubation in 10 mM EDTA for 54 days, and then (I) the sample was placed 
back in 10 mM EDTA for 72 days. 
Since the use of 10 mM EDTA interfered in the CD readings, to circumvent this 
problem a lower concentration of 0.33 mM determined by trials (protein concentration 
for the entire cassette was 0.5 mg/ml) was used in the following tests (Figures 18A-C). 
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After 10 days of incubation, the WT structure began to lose its native configuration 
accompanied by a decrease in negative ellipticity between the region 220-230 ran and 
207-200 nm, which indicated metal loss (Figure 18C). When the incubation temperature 
was increased to 37°C, a change in the spectrum was observed after one day of 
incubation (Figures 18D-E). After two days, metal loss was observed (Figure 18E). After 
four days, metal loss appeared to be complete, as indicated by the loss in the secondary 
structure relative to the metallation reference spectrum in Potter and co-workers (2007) 
(Figure 18F). 
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Figure 18. CD spectra in the far-UV of encapsulated WT SOD1 as a function of 0.33 
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Encapsulated A4V protein that was incubated in 10 mM EDTA at 4°C showed an 
increased negative ellipticity in the region between 225-240 ran and 200-220 run (Figures 
9+ 
19A-B). To confirm the possibility of metal loss, Zn was added after removal of 
EDTA, and a corresponding change was detected in the 200-220 nm region (Figure 19B). 
When the sample was placed back in EDTA, a corresponding change was observed in the 
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same region (Figure 19C). These changes suggest that the Zn was added to the apo-
A4V protein. However, the changes in the structure did not agree with the work of Potter 
and co-workers (2007) done in solution on apo-WT protein. Most likely mismetallation 
happened in the mutant A4V SOD1 because of the abnormalities in the metal-binding 
properties of the zinc-binding site due to the mutation (Valentine et al., 2005). It is 
important to note that changes in the CD signal observed between 225-240 nm were also 
encountered with other A4V signals under various conditions such as pH 4.0 and 5.7, and 
that the addition of metal does not have effects on that part of the spectrum. 
Another A4V sample was used to confirm the demetallation effect under milder 
conditions (0.33 mM EDTA). After five days of incubation in 0.33 mM EDTA, a 
significant change was observed in the CD regions between 225-240 nm and 200-220 nm 
(Figures 19D-E). Then the temperature was raised to 37°C for 10 minutes, and the 
sample was measured. Next, the same sample was again incubated at 37°C for two 
consecutive 15-minute periods, and readings were obtained. The corresponding change 
in the secondary structure (Figure 19E) shows that the initial 10-minute period did most 
of the damage (increase in the negative ellipticity in the above mentioned regions). The 
complete unfolding of the structure took place after 28 days at 4°C (Figure 19F). These 
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observations also suggest the presence of apo-A4V protein. Finally, subjecting the 
encapsulated A4V sample to one day at 37°C in the presence of 0.33 mM EDTA 
produced irreversible unfolding of the secondary structure (Figures 19G-H). 
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Figure 19. CD spectra in the far-UV of encapsulated A4V SOD1 under the effect of 
EDTA. See legend on the following page. 
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Figure 19. Legend: 
(A) The first sample was incubated in 10 mM EDTA at 4°C for 2 and 12 days followed 
by addition of Zn ion for 1 and 7 days then placed back in 10 mM EDTA for 29 days, 
(B) effect of Zn ion after 1 and 7 days on the CD signal of A4V protein incubated in 10 
mM EDTA for 12 days, (C) after 29 days in 10 mM EDTA at 4°C. (D) The second 
sample incubated in 0.33 mM EDTA for 1 and 5 days at 4°C followed by 10, 15 and 15 
minutes at 37°C, and then for 28 days at 4°C, (E) effect of temperature was monitored 
after 1 and 5 days at 4°C, then at 10, 15 and 15 minutes at 37°C and (F) after 28 days at 
4°C. (G) The third sample was placed in 0.33 mM EDTA at 37°C for 1 day, then at 4°C 
for 2, 6, 28, and (H) 28 days. 
3.4 Fourth Aggregation Condition: Reducing the Disulfide Bond Using DTT or 
TCEP 
Two reducing agents were used, namely DTT and TCEP, to characterize the 
effect of disulfide bond reduction on both the WT and A4V proteins. Literature reports 
provided contradicting results: Arnesano and co-workers (2004) stated that reducing the 
disulfide bond should have no effect on the secondary structure of WT protein; however 
Fujiwara et al. (2005) showed some loss of the structure using CD. It is expected that 
upon reducing the disulfide bond a general destabilization of the secondary structure 
would occur. In this work, it was found that slight variations in the test conditions 
influenced the secondary structure of the encapsulated reduced SOD1. The effects of 
TCEP are studied first, followed by DTT. The samples incubated in 40 mM TCEP and 6 
mM DTT were washed with purified water and incubated in 10 mM Tris buffer at pH 7.0 
for about 30 minutes prior to testing in order to decrease the noise level. 
Initially, a WT SOD1 sample was reduced using 40 mM TCEP, pH 5.5, and 
stored at 4°C (Figures 20A-C). The results seemed to agree with Arnesano and 
colleagues (2004). There was a minor change in the 200-205 nm range, which was not 
significant enough to justify a new finding. On the other hand, when reduction took 
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place at 37°C, the WT protein unfolded within one day of incubation (Figures 20D, E). It 
seems that increasing the temperature enabled the structural changes in reduced WT 
protein. In addition, when two other older samples, previously used to study the long-
term effects of pH 5.7 and pH 4.0, were subjected to TCEP treatment, major secondary 
structural changes were noticed in Figures 20F-H and Figures 20I-K, respectively. The 
reduced secondary structure under the effect of pH 4.0 became more random coil. 
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Figure 20. Legend: 
(A) The first sample was incubated in 40 mM TCEP at 4°C and reading were obtained 
for 1, 2, 3, 4 and 10 days; (B) 2 and 4 days and (C) 10 days. (D) The second sample was 
incubated at 37°C, and readings were monitored for 4 consecutive days with (E) 
showing day 4. (F) The third sample was previously in KOAc at pH 5.7 for 54 days at 
4°C, and reduced with 40 mM TCEP for 1 day, then placed in KOAc, pH 5.7 for 2 days, 
put in Tris, pH 7.0, for 6 days and then placed back in KOAc, pH 5.7 for 2 days; (G) 
reduced WT protein in KOAc, pH 5.7, for 2 days; (H) effect of KOAc, pH 5.7, for 2 
days after incubation in Tris, pH 7.0, for 6 days. (I) The fourth sample previously placed 
in KOAc, pH 4.0, for 54 days at 4°C, was reduced with 40 mM TCEP for 1 day and 
then put in Tris, pH 7.0, for 2 and 6 days, and finally incubated in KOAc, pH 4.0, for 6 
days; (J) in KOAc at pH 4.0 for 54 days, then placed in Tris at pH 7.0 for 2 days after 1 
day in 40 mM TCEP, then left in Tris, pH 7.0 for 6 days, and (K) placed in KOAc, pH 
4.0 for 6 days. 
To study the effects of DTT on the secondary structure, three WT samples 
encapsulated in sol-gel made with KOAc, pH 5.7, were reduced with 6 mM DTT, pH 5.5, 
and stored at 4°C. Then, each sample was washed with purified water and then placed in 
a different buffer, at pH 7.0, 5.7 and 4.0, to monitor the effect on the secondary structure 
(Figures 21 A-1). In buffer of physiological pH, the reduced WT protein maintained the 
native structure (Figures 21A-C). Also, in pH 5.7 buffer, no major changes occurred in 
the secondary structure (Figures 21D-F). However, at pH 4.0 the reduced WT protein 
went through a conformational change, exhibiting a CD signal around 215 nra that is 
reminiscent of a p-structure. After two weeks, the protein refolded to an altered 
conformation similar to the reference, but with a major difference in the CD region 
between 210-200 nm (Figures 21G-I). It is important to note that the previous oxidized 
WT samples that were subjected to pH 4.0 at 4°C did not show the major structural 
change in the reduced WT sample shown in Figure 21H. This suggests that even though 
reducing the disulfide bond did not produce an apparent change in the secondary 
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structure, something else may have changed in order for the reduced protein to produce 
different results when placed in pH 4.0. Perhaps future studies could investigate these 
further using techniques other than far-UV CD that was solely used in this study. One 
possible method could be a fluorescent quenching technique to study modifications in the 
protein conformation (Pierre, 2004). 
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Figure 21. Legend: 
(A) The first sample was in 6mM DTT for 2 days, then in Tris, pH 7.0, for 4 days; (B) 
showing spectrum in 6 raM DTT for 2 days and (C) in Tris, pH 7.0, for 4 days. (D) The 
second sample was in 6 mM DTT for 2 days followed by KOAc, pH 5.7, for 4 and 18 
days; (E) in 6 mM DTT for 2 days, and (F) in KOAc, pH 5.7, for 18 days. (G) The third 
sample was in 6 mM DTT for 2 days followed by KOAc, pH 4.0, for 4 and 18 days; (H) 
in KOAc, pH 4.0 for 4 days, and (I) for 18 days. 
Next, the effects of TCEP on encapsulated A4V protein were investigated. Three 
samples were used. Two samples were treated with TCEP first, and then put in different 
buffers, one in Tris, pH 7.0, and the other in KOAc, pH 5.7. The third sample was 
initially placed in KOAc, pH 4.0, and then treated with EDTA. The TCEP concentration 
was 40 mM at pH 5.5 for all the samples. 
The samples that were initially treated with TCEP showed a similar 
destabilization to the secondary structure (Figure 22). Also, the subsequent pH condition 
at pH 4.0 did show additional deterioration indicating a possible metal loss. To confirm 
this, EDTA was added to the sample that was in pH 4.0 (Figures 22G-I), and the resulting 
signal (Figure 22H) was nearly identical, thus confirming that the metal loss occurred in a 
prior step. This loss of metals could be a consequence of the destabilization in the A4V 
protein due to the mutation, even though Hough and co-workers indicated that the metal 
binding sites were unaffected by the mutation (Hough et al., 2004). However due to the 
destabilization in the dimer interface caused by the mutation of alanine to valine, 
unfolding or metal loss in vivo may result (Hough et al., 2004). Finally, the A4V protein 
unfolded (Figures 22G-I) after seven days at pH 4. This unfolding was irreversible since 
the sample was monitored for an additional 16 days with no change in the structure. 
62 
The third sample that was initially placed in pH 5.7, then in TCEP, showed 
similar initial deterioration, but after five days in TCEP, the metal loss was not observed, 
although the protein fully unfolded after 29 days in TCEP (Figures 22D-F). 
Finally it is important to note that the encapsulated oxidized A4V protein 
incubated in pH 7.0 buffer did not exhibit similar changes in the secondary structure, 
even after 54 days of incubation (Figure 10E), as compared to the reduced encapsulated 
A4V protein in pH 7.0 (Figures 22A-C). 
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See legend on the following page. 
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Figure 22. Legend: 
(A) The first sample was incubated in 40 mM TCEP for 2 days, then in Tris, pH 7.0, for 
1 and 6 days; (B) in 40 mM TCEP for 2 days followed by Tris, pH 7.0 for 1 and (C) 6 
days. (D) The second sample was in KOAc, pH 5.7, for 2 days then in 40 mM TCEP 
for 5 and 29 days; (E) in KOAc, pH 5.7, for 2 days followed by 40 mM TCEP for 5 
days, and (F) in 40 mM TCEP for 5 and 29 days. (G) The third sample incubated in 40 
mM TCEP for 2 days followed by KOAc, pH 4.0, for 5 days, 30 mM EDTA for 5 days 
and then in KOAc, pH 4.0 for 7 and 16 days; (H) in 40 mM TCEP for 2 days, KOAc, 
pH 4.0 for 5 days and 30 mM EDTA for 5 days; (I) in KOAc, pH 4.0 for 5 days and 16 
days. 
The CD spectra of reduced A4V protein, with 6 mM DTT, pH 5.5, at 4°C, again 
showed an increased negative ellipticity between 250-220 nm (refer to Figures 23A-F). 
Similar observations can be made in this section to those described with the prior TCEP 
section. These results are in line with previous work done with SOD1 in solution (Tiwari 
and Hayward, 2003; Fujiwara et al., 2005). Furthermore, the same CD regional change 
mentioned above was also observed when A4V protein was incubated under other 
destabilizing conditions such as pH 4.0 or addition of EDTA. This common change in 
the CD spectra could be related to the A4V mutation, which decreases the global stability 
of the protein (Hough et al., 2004). The A4V protein was shown to be more susceptible 
to disulfide reduction than WT SOD1 protein in the present work. 
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Figure 23. CD spectra of encapsulated A4V SOD1 following treatment with DTT. (A) 
The first sample was incubated in 6mM DTT for 4 days, then in Tris, pH 7.0, for 2 and 
16 days, (B) in Tris, pH 7.0, for 2 and (C) 16 days. (D) The second sample was 
equilibrated in 6 mM DTT for 4 days followed by KOAc, pH 5.7, for 2, 16 and 50 days, 
(E) in KOAc, pH 5.7, for 2, and (F) 16 and 50 days. (G) The third sample was in 6 mM 
DTT for 4 days followed by KOAc, pH 4.0, for 2 and 16 days, (H) in KOAc, pH 4.0 for 
2, and (I) for 16 days. 
3.5 Fourth Aggregation Condition: TFE and Methanol 
The denaturant effects of alcohols such as 2,2,2-trifluoroethanol (TFE) on protein 
structure originate from the alcohol's low polarity, which is believed to interfere with the 
hydrophobic forces stabilizing protein structure through the alcohols direct interactions 
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with water (Voet and Voet, 2004). Furthermore, TFE has been shown to induce a helical 
conformation in an all p-barrel protein (Srisailam et al., 2003). Also, methanol can cause 
the formation of helical structure or p-like structure (caused by aggregation of the helical 
intermediate form) depending on the specific protein or polypeptide (Wang et al., 1992). 
Therefore encapsulated WT and A4V proteins were tested with various concentrations of 
TFE and methanol to investigate the effect of these denaturants on the secondary 
structure of SOD 1. All samples were encapsulated in sol-gel glasses made with KOAc, 
pH 5.7. A4V samples that were previously exposed to different conditions were replaced 
with various concentrations of TFE and methanol. 
Three different WT glass samples were used. The first one was incubated in 15% 
TFE at 4°C for four consecutive days. A CD reading was obtained for each incubation 
day (Figures 24A-C). A change in the CD signal in the region around 208 nm was 
detected indicating an increase in the helical content of the structure (Sreerama and 
Woody, 2004). The next two samples were used to compare the effects of TFE and 
methanol on WT secondary structure. The two samples started with identical initial 
conditions, i.e., physiological pH and then 15% TFE at 4°C. When TFE concentration 
and temperature were increased to 80% at 37°C, the secondary structure in the first 
sample unfolded within one day (Figures 24D-F). Interestingly, when methanol was 
added instead of TFE to the second sample, the secondary structure was largely restored 
to its native conformation (Figures 24G-I). This recovery of the native conformation has 
not been observed before. 
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Figure 24. CD spectra in the far-UV of encapsulated WT SOD1 due to the effect of 
TFE and methanol. (A) The first sample was placed at 4°C in 15% TFE for 1, 2, and 4 
days, (B) for 1, 2, and (C) 4 days. (D) The second sample was in Tris, pH 7.0, for 1 day 
followed by 15% TFE at 4°C for 5 days then in 80% TFE for 1 day at 37°C, (E) in 
15% TFE at 4°C for 5 days, and (F) in 80% TFE for 1 day at 37°C. (G) The third 
sample equilibrated in Tris, pH 7.0 at 4°C for 1 day, 15% TFE at 4°C for 5 days then in 
80% MeOH for 1 day at 37°C, (H) in 15% TFE at 4°C for 5 days, and (I) in 80% MeOH 
for 1 day at 37°C. 
Two samples were used to study the effect of TFE and methanol on the secondary 
structure of mutant A4V protein. The first sample was previously incubated in Tris, pH 
7.0, at 4°C for two months. The near-native conformation was documented in Figures 
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10D-E. Addition of TFE was performed to determine its effects on the A4V protein 
exhibiting the stable near-native conformation since TFE has been shown to induce 
aggregation in SOD1 (Stathopulos et al, 2003). Upon the addition of 15% and then 
45% TFE at 37°C, an increase in negative ellipticity was detected in the CD regions 
around 208 nm (similar to WT SOD1) and 225-235 nm. So, by increasing the TFE 
concentration, A4V protein began to unfold (Figures 25A-C). The second experiment 
used an A4V protein sample incubated in Tris, pH 7.0 for one month at 4°C. The CD 
spectrum showed the loss of the prominent band in the region 228-230 nm, which is a 
common feature observed in A4V protein under various aggregation conditions, i.e., low 
pH with KOAc pH 5.7 and 4.0, (sections 3.2.2 and 3.2.3), EDTA (section 3.3), and 
TCEP/DTT (section 3.4). When TFE was added at 4 and 37°C, no change in the 
secondary structure was observed (Figures 25D-E). When low concentration of methanol 
(15%) was added, the CD signal intensity decreased indicating leaching of some of the 
encapsulated protein out of the sol-gel matrix (Figure 25F). The third experiment used a 
reduced A4V protein sample. When various concentrations of TFE were added at 4 and 
37°C, similar results were obtained as with the two previous experiments (Figures 25G-
H). When 80% methanol was added at 37°C, the A4V protein adopted a new 
conformation with a distinct minimum in the CD region at around 215 nm as compared to 
208 nm in the native structure (Figure 251). This minimum has been observed before 
with the WT spectra but not with the A4V spectra. Further research needs to be done 
using new samples of encapsulated A4V SOD1 to better understand the effects of TFE 
and methanol. 
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Figure 25. CD spectra in the far-UV of encapsulated A4V SOD1 as a function of TFE 
and methanol. (A) The first sample was incubated at 4°C in Tris, pH 7.0, for 2 days, 
then for 2 months followed by 15% TFE for lday, and for 2 hours at 37°C, then in 
45% TFE for 1 day at 37°C, (B) in 15% TFE for 2 hours at 37°C, and (C) 45% TFE for 
1 day at 37°C. (D) The second sample was equilibrated in Tris, pH 7.0, for lmonth at 
4°C followed by 15% TFE at 4°C for 1 day at 4°C and for 2 hours at 37°C, then in 15% 
TFE for 1 day at 37°C, (E) in Tris, pH 7.0, for 1 month, in 15% TFE for 1 day at 4°C 
and 2 hours at 37°C (F) in 15% MeOH for 1 day at 37°C. (G) The third sample was 
placed in 6 mM DTT for 2 days, in KOAc, pH 5.7 for 50 days, in 15% TFE for 1 day, in 
25% for 1 day at 4°C, then in 15% TFE at 37°C followed by 45% TFE for 1 day and 
then in 80% MeOH for 1 day at 37°C, (H) in KOAc, pH 5.7 for 50 days, then in 15% 
TFE for 1 day at 4°C, then in 80% MeOH for 1 day at 37°C and (I) in 80% MeOH for 1 
day at 37°C. 
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3.6 Other Test Conditions 
3.6.1 Effects of Salts on the Secondary Structure of hSODl 
Some salts are known to have stabilizing effects on protein structure while others 
have the opposite or no such effect (Jain and Ahluwalia, 1996). In this work, N(CH3)4C1 
(TMAC1) was used to study its effects on the encapsulated hSODl proteins. This salt 
was selected since it has been shown to have stabilizing effects on encapsulated proteins 
that were denatured either due to the encapsulation process or through intentional 
chemical denaturing (Eggers and Valentine, 2001b). In addition this salt exhibited 
minimum interference with the CD spectrum in the far-UV region, which makes it a 
perfect candidate for this study. 
Two encapsulated WT samples and one A4V sample were incubated in 1.0 M 
N(CH3)4C1, pH 7.0 and stored at 4°C. The first WT sample was encapsulated in a 
standard sol-gel made with KOAc buffer at pH 5.7 (Figures 26A-C), and the second 
sample was encapsulated in a sol-gel made with Tris buffer, pH 7.0 (Figures 26D-F'). 
Both samples were monitored for 54 days. A4V protein was encapsulated in a standard 
sol-gel made with KOAc buffer, pH 5.7 (Figures 26G-H), and the sample was monitored 
for 2 days. The spectra shown in Figures 26A-H indicate that N(CH3)4C1 had a 
destabilizing effect on the secondary structure of the encapsulated protein. This was 
surprising given that previous studies have shown opposite effects. The possible causes 
for this apparent conflict are discussed in detail in Chapter 4. 
The final conformations of the encapsulated proteins are compared in Figure 27 
after normalization. The loss of the CD signal in the case of WT protein encapsulated 
with sol-gel made with Tris buffer at pH 7.0, as shown in Figures 26D-F', is suspected to 
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be mainly due to the pore size being larger as compared with the pore size of the sol-gel 
made with pH 5.7 buffer. This is consistent with other CD measurements observed in 
this study as will be discussed in section 3.6.2. The minor normalization for the A4V 
signal was necessary due to the length of the incubation period (2 vs. 54 days) rather than 
the pore size. This, unfortunately, was needed since the sample broke after the second 
measurement. Interestingly, the CD spectra of the encapsulated A4V and WT proteins 
were almost identical in this case, whereas in most other test conditions different effects 
were observed on the encapsulated A4V and WT proteins. 
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Figure 26. CD spectra in the far-UV of encapsulated WT and A4V SOD1 protein 
equilibrated in 1M N(CH3)4C1. See legend on the following page. 
73 
Figure 26. Legend: 
(A) The first WT sample was encapsulated in standard sol-gel made with KOAc buffer, 
pH 5.7 and monitored for 1, 2, 3, 7, 9, 11 and 54 days, (B) 7 and 11 days and (C) 54 
days. (D) The second WT sample was encapsulated in standard sol-gel made with Tris 
buffer, pH 7.0 and monitored for 1, 2, 3, 7, 9, 11 and 54 days, (E) 7 and 11 days and (F) 
54 days. (D', E', and F') are normalized for D, E and F respectively. (G) A4V sample 
encapsulated in standard sol-gel made with KOAc buffer, pH 5.7 and monitored for 1, 2 
and, (H) 2 days. 
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Figure 27. Comparison of final conformations of encapsulated WT and A4V SOD1 
incubated in 1.0 M N(CH3)4C1. A4V sample encapsulated in standard sol-gel made with 
KOAc buffer, pH 5.7 was incubated for 2 days is compared to WT samples incubated 
for 54 days (in sol-gel made with KOAc buffer, pH 5.7 and with Tris buffer, pH 7.0 
normalized signal). Both WT and A4V references are shown. 
3.6.2 Effect of pH 8.0 on the Encapsulated hSODl 
Protein leaching out of the sol-gel pores presented a major problem in this 
research. It was noted that as the pH increased from 5.7 to 7.0, so did the leaching from 
the sol-gel. This loss could be attributed to the electrostatic interaction between the sol-
gel matrix and the protein. Human SOD1 is predicted to have an isoelectric point (pi) 
around 5.8, hence at pH 7.0 and above the protein carries a net negative charge (Shaw 
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and Valentine, 2006). In addition, the silica pi is about 2.1, so at higher pH the silica 
walls become negatively charged (Nguyen et al., 2002) and that would create an 
electrostatic force that would repel the protein from the pores. To confirm this 
observation, two encapsulated WT samples and one encapsulated A4V sample were 
incubated in Tris buffer, pH 8.0 at 4°C for 54 days and 12 days, respectively. As will be 
discussed further in chapter 4, the net charge of the protein in pH 8.0 buffer is expected to 
be significantly more negative as compared with that in pH 7.0 (-7.3 and -3.2, 
respectively). The low temperature (i.e., 4°C) slowed down the leaching process and 
allowed careful monitoring of the loss rate. The two WT samples were prepared using 
the standard sol-gel protocol. One was made with Tris buffer, pH 7.0 (Figures 28A-A') 
and the other was made with KOAc buffer, pH 5.7 (Figures 28B-B'). Similarly, the A4V 
sample was prepared using the latter method (Figures 28C-C). 
First, the general trend is established by comparing the spectra shown in Figure 
11, Figures 10A-C, and Figures 28A-B corresponding to WT samples incubated in 
different buffers with pH 5.7, pH 7.0 and pH 8.0, respectively. This confirmed that as the 
pH increased, the protein signal decreased. Similarly, for the encapsulated A4V sample, 
by comparing the spectra shown in Figure 28C and Figures 14A-B, an analogous trend is 
observed. In order to determine the rate of protein leaching due to the above 
observations, the normalization factors used to achieve the same ellipticity value near the 
minimum are used to calculate the loss percentage under various conditions. As shown 
in Figure 29, the rate of protein leaching correlates with the buffer pH as well as the sol-
gel preparation method. Under identical incubation conditions, the extent of leaching of 
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S0D1 encapsulated in standard sol-gel glasses made with KOAc buffer at pH 5.7 is 
found to be always lower than that encapsulated in sol-gel glasses made with Tris buffer 
at pH 7.0. This suggests that the pore size is smaller for the sol-gel prepared with pH 5.7 
as compared with pH 7.0. In addition, the pH of the buffer used for incubation appears to 
have a more significant effect on SOD1 leaching rate as shown in Figure 29. 
76 
Protein: WT 
Buffer: 
Tris, pH 8.0 
Storage Temp.: 
4°C 
Standard sol-gel: 
Made with 
Tris, pH 7.0 
Protein: WT 
Buffer: 
Tris, pH 8.0 
Storage Temp.: 
4°C 
Standard sol-ge 
Made with 
KOAc, pH5.7 
Protein: A4V 
Buffer: 
Tris, pH 8.0 
Storage Temp.: 
4«C 
Standard sol-gel: 
Made with 
KOAc, pH 5.7 
0' 
o 
E -2-
•o 
*E -3-
o> 
^ -4" 
o -5. 
E1 -6' 
-7-
I A 
^T 
N^^ **~~™ "^ 
x^S**^ 
t\V***' 
<^//f /JI-
/y/l /// 
f 
Wt reference 
— 1day 
—«— 2 days 
- • — 3 days 
— 7 days 
—«— 9 days 
11 days 
54 days 
— 1 1 
Normalized 
-1 • 
-2-
-3' 
-4-
-5 ' 
-6 ' 
- 7 • 
A' ^ ^ ^ ^ 
i 
f Wt reference 
—•—1day 
-^—2 days 
—•—3 days 
—»-7days 
— 9 days 
— 1 1 days 
54 days 
1 1 1 
200 210 220 230 
Wavelength (nm) 
240 250 200 210 220 230 
Wavelength (nm) 
240 250 
210 220 230 
Wavelength (nm) 
210 220 230 
Wavelength (nm) 
250 
Figure 28. CD spectra in the far-UV of encapsulated WT and A4V SOD1 incubated in 
Tris pH 8.0 at 4°C. (A) WT sample was encapsulated in standard sol-gel made with Tris 
buffer, pH 7.0 and monitored for 1, 2, 3, 7, 9, and 54 days. (B) WT sample was 
encapsulated in standard sol-gel made with KOAc buffer, pH 5.7 and monitored for 1, 2, 
3, 7, 9, and 54 days. (C) A4V sample encapsulated in standard sol-gel made with KOAc 
buffer, pH 5.7 and monitored for 1 and 12 days. (A', B', and C ) are normalized for A, 
B and C respectively. 
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Figure 29. Effects of buffer pH and sol-gel preparation methods on encapsulated 
protein-leaching rate. 
3.6.3 Bovine SOD1 (bSODl) Tests under Various Conditions 
Parallel tests were conducted using bSODl, rather than human WT or A4V, in 
order to establish test guidelines and to avoid the potential waste of the limited amount of 
WT and A4V proteins available for this study. These tests were primarily focused on 
addressing the following: 1) Effects of the sol-gel encapsulation on the protein's 
secondary structure as compared with that in solution when incubated in pH 7.0 buffer. 
2) Stability of the encapsulated protein under various test conditions and determination of 
how long the protein structure remains stable in the encapsulated environment. 3) Effects 
of the different types of sol-gel glasses used in this study (i.e., 100% TMOS and 10% 
propyl-modified glass). 4) Changes in the secondary structure of the protein under the 
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influence of various pH, salts, and other aggregation conditions such as low pH, EDTA, 
and heat. 
First, the CD spectrum of native bSODl in solution (10 raM Tris, pH 7.0) was 
obtained and compared with the literature (Foti et al., 1997). Both signals were similar, 
and the spectrum obtained was used as the bSODl reference for all the following tests 
(Figure 30). Next, two different encapsulation processes were used to determine the 
impact on the secondary structure. The first encapsulation process was based on the 
standard sol-gel method described in (Eggers and Valentine, 2001a), and the buffer used 
was Tris, pH 7.0. The second process included a 10% propyl-modified sol-gel. As 
shown in Figure 30, the encapsulation processes produced minor effects on the secondary 
structure of bSODl protein. 
Protein: bSODl 
Buffer: 
Tris pH 7.0 
Storage Temp.: 
4°C 
sol-gels: 
• standard sol-gel 
made with Tris, 
pH7.0 
•10% Propyl-
modified glass 
0 -
- 1 • 
f-2-
y -4-
x -6-
S1 
- 7 -
\" r^*~ 
l\ / 
\ \ g •- "•' bSOD reference 
T& J P " • pH 7.0 (standard sol-gel 
*&r made with pH 7.0) 
—•—pH 7.0 (sol-get made 
with 10% propyl) 
1 1 1 1 
200 210 220 230 240 250 
Wavelength (nm) 
Figure 30. Effects of the encapsulation process on bSODl. The first sample was 
encapsulated with a standard sol-gel protocol, and the other sample with a 10% propyl-
modified sol-gel protocol. Both samples were incubated with Tris buffer, pH 7.0, at 
4°C. bSODl in solution was used as the reference. 
Protein leaching out of the sol-gel pores, causing loss of the CD signal, was a 
major problem for this protein. To circumvent this issue, sol-gel samples were used 
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immediately after the two weeks of maturation, and samples were kept at 4°C except 
during CD measurements, which were conducted at 25°C unless stated otherwise. As 
observed in Figure 31, most of the samples had a sufficient amount of protein to produce 
a good CD signal even after 12 days of incubation, although the samples incubated in 10 
raM Tris buffer at pH 8.0 and N(CH3)4C1 were weaker. The two different encapsulation 
processes also produced similar spectra (Figures 31A-F' and Figures 31I-F) except for 
N(CH3)4C1. The effects of N(CH3)4C1, as described previously, are discussed further in 
Chapter 4. Finally, the denaturation effects resulting from heat treatment, as shown in 
Figure 31H, are not only irreversible, but in fact appear to continue further when the 
sample is stored at 4°C after treatment. 
The effects of the different encapsulation processes on the secondary structure of 
bSODl are compared under various incubation conditions (Figures 32A-C). Again no 
major difference is observed aside from the N(CH3)4C1 case, which is the same data 
shown in Figures 31F-F'. 
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Figure 31. CD spectra in the far-UV of encapsulated bSODl incubated in various 
conditions. See legend on the following page. 
81 
Figure 31. Legend: 
Samples in spectra from (A-H) were encapsulated in a 10% propyl-modified glass, and 
incubated for 12 day at 4°C with the exception of the sample in (G-H). (A). Samples 
were incubated in Tris buffer, pH 7.0, (B). in KOAc buffer, pH 5.7, (C). in KOAc 
buffer, pH 4.0, (D). in EDTA, (E). in Tris buffer, pH 8.0, (E'). Normalization of (E), 
(F). inN(CH3)4Cl and (F'). Normalization of (F). (G). bSODl sample was incubated in 
Tris, pH 7.0, for 1 day and then heated from 25-95°C, afterward stored at 4°C, and 
readings were taken after, (H). 4, 6 and 12 days. (I). CD readings were obtained of 
samples encapsulated in the standard sol-gel and incubated for 1 day at 4°C in Tris, pH 
7.0 and 8.0, KOAc, pH 5.7 in EDTA and N(CH3)4C1. bSODl in solution was used as the 
reference. 
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Figure 32. Comparison of CD spectra in the far-UV of encapsulated bSODl using the 
standard sol-gel and the 10% propyl-modified glass in various buffers. All samples (A-
C ) were incubated for 1 day at 4°C. (A). Samples were incubated in Tris, pH 8.0, (B) 
in KOAc, pH 5.7, (C) in N(CH3)4C1, and (C) Normalization of (C). bSODl in solution 
was used as the reference. 
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3.6.4 Other Test Conditions: Xerogel 
Encapsulation of WT SOD1 in xerogel was investigated under five conditions. 
While samples incubated in Tris buffer, pH 7.0, KOAc, pH 5.7 and EDTA unfolded, the 
sample incubated in N(CH3)4C1 did not (Figures 33A-A'). Given that in the xerogel 
protocol more shrinkage and water loss occurred as compared with the standard wet-aged 
sol-gel process, the resulting average pore sizes are assumed to be much smaller (Pierre, 
2004). This could contribute significantly to the loss of the secondary structure of the 
protein due to the presence of small amount of entrapped water surrounding the protein in 
the pores as well as the silica matrix interaction (Eggers and Valentine, 2001a, 2001b). 
The beneficial effects of N(CH3)4C1 in this case are discussed in Chapter 4. 
Protein: WT 
Buffers: 
• Varies 
• Incubated in 
buffer for 1 day. 
Storage Temp.: 
4°C. 
Standard sol-gel: 
Made with 
Tris, pH 7.0 
dried to produce 
Xerogel. 
Figure 33. CD spectra in the far-UV of encapsulated hSODl WT in xerogel. (A). 
Samples were incubated in Tris buffer, pH 7.0, KOAc buffer, pH 5.7, EDTA and 
TMAC1 for 1 day at 4°C. (A') normalization of (A). The reference is a sample of WT 
encapsulated in standard sol-gel incubated in Tris buffer, pH 7.0, at 4°C. 
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CHAPTER 4 
4.0 Discussion and Conclusions 
This study demonstrates that the encapsulation of CuZnSOD proteins (human 
WT, mutant A4V, and bovine) in sol-gel matrices is a viable approach to isolate 
intermediates that would normally lead to aggregation in dilute solutions. The findings in 
this study are pertinent from two perspectives. First, since protein aggregation in solution 
is inevitable under various denaturing conditions, establishing the effects of such 
conditions on the structure of these proteins is difficult, if not impossible, in some cases. 
This is especially true for the mutant SOD1 A4V protein since it has been shown to 
aggregate spontaneously in vitro under conditions at which the WT protein remains stable 
(Ray et al., 2004). Second, the effects on protein structure due to molecular crowding 
and confinement in the cellular environment are mimicked by protein encapsulation in 
the sol-gel (Eggers and Valentine, 2001a). Given that most of the previous studies on 
SOD1 have been conducted in dilute solutions, understanding the influence of the highly 
crowded cellular environment on protein stability and dynamics is of great interest 
(Zimmerman and Minton, 1993; van den Berg et al., 1999; Ellis, 2001; Zhou and Dill, 
2001). The secondary structure of the entrapped proteins was investigated using circular 
dichroism in the far-UV region (200-250 ran). Near-UV measurements and tertiary 
structure impact were out of scope in this study given the limited amount of protein 
available (i.e., protein concentration in the samples should be at least five times that used 
in this study). Various sol-gel processes were investigated as described below, and two 
types of wet-aged sol-gels were found to be most suited for hSODl entrapment with low 
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protein concentration. Finally, the influences of several denaturing conditions on the 
secondary structure of entrapped proteins are explored further in this chapter, and the 
most important finding of a "stabilized partially unfolded state" will be discussed at the 
end of this chapter. 
4.1 Impact of the Various Sol-gel Methods on the Structure of Encapsulated 
Proteins 
In this section, general findings related to the effects of sol-gel encapsulation, 
pore sizes, entrapped water and pH are discussed. 
4.1.1 Sol-gel Methods: Summary and Findings 
Four sol-gel preparation methods were investigated in order to determine the 
impact of encapsulation on protein structure as well as to find a way to limit the protein 
leaching problem that plagued the initial tests. The silica sol preparation methods used in 
this study were based on the standard protocol described in the literature (Ellerby et al., 
1992; Eggers and Valentine, 2001a). These methods are enumerated in the following 
with the associated impact on protein structure and leaching. 
1. Standard wet-aged gels: The silica sols were prepared using two different buffers, 
namely, Tris, pH 7.0, and KOAc, pH 5.7. For brevity, the resulting glasses 
7 0 
containing the entrapped proteins are referred to, hereinafter, as sol-gel and sol-
gel5 7, respectively. WT SOD1 was encapsulated using both gel types, whereas the 
mutant A4V protein was encapsulated only in sol-gel5 7 due to the limited amount of 
7 0 
protein available. Bovine SOD1 was encapsulated using sol-gel and other sol-gel 
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types as described below. In the absence of denaturant, protein encapsulation in 
these glasses was found to induce a very minor change to the protein's structure as 
compared with that in solution at pH 7.0 at 25°C (Figure 8A). However, protein 
leaching was higher with sol-gel7 ° as compared with sol-gel5'7, particularly when the 
glasses were incubated in buffers with a pH higher than the protein's pi ~ 5.8 (i.e., 
when the encapsulated protein is negatively charged). In the presence of 
denaturants, the encapsulated proteins in these different glasses exhibited slightly 
dissimilar structural changes under identical incubation conditions with few 
exceptions. The most probable cause for this, as discussed in section 3.6.2, is that 
the average pore size of sol-gel7 ° is larger than sol-gel5'7. This would explain both 
the higher protein leaching observed with sol-gel70 as well as the slight difference in 
the structural changes of the encapsulated proteins under various incubation 
conditions. 
2. Xerogel: This method was considered for two reasons: 1) it offered a potential 
means to eliminate the protein leaching problem; 2) xerogels are less brittle than 
wet-aged sol-gels that broke more often than desired. Unfortunately, the resulting 
CD signal intensity was extremely weak, and the protein denatured significantly. 
While in a previous study, bovine SOD1 was successfully encapsulated in a xerogel 
and remained active (Ellerby et al., 1992), the concentration used in that study was 
about forty times that of the concentration used in this study (0.65 mM vs. 0.0156 
mM). Thus, the higher concentration was not an option for this study based on the 
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required amount of protein and the fact that the absorbance would be too high for 
CD measurements in the far-UV. 
3. Propyl modified glass: The addition of the propyl groups to the silica matrix was of 
interest based on the results reported in previous studies (Pierre, 2004; Rocha and 
Eggers, 2007); however, the encapsulation of SOD 1, using this method, resulted in 
leaching of the protein. Consequently, the CD signal intensity was very weak in 
comparison with the 100% TMOS (standard) glass even when an identical protein 
concentration was used in the preparation. Therefore, with the 10% propyl-modified 
glass, the protein concentration needed in the sample should be more than doubled 
that of the standard glass to compensate for the leaching problem. In addition, the 
physical nature of the 10% propyl-modified glass samples was found to be 
extremely brittle. This resulted in a large percentage of samples breaking due to 
handling (i.e., removal from the quartz cuvette for storage and the reverse process). 
As a result, aside from the bSODl encapsulation tests shown in section 3.6.3, this 
method was not preferred for hSODl encapsulation. 
Thus, most of the experiments in this study used the standard wet-aged sol-gel for 
encapsulating both WT and A4V SOD1. The protein leaching issue was partly addressed 
by using sol-gel5' for most of the tests, as well as storing the samples at 4°C, which was 
found to lower the leaching rate further. Lastly, in cases where protein leaching could 
not be avoided (i.e., when the pH buffer was higher than the protein's pi 5.8), CD data 
normalization was used to compensate for the resulting loss of protein concentration (i.e., 
approximate the signals at the same concentration). 
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4.1.2 Impact of Sol-gel Pore Size on Encapsulated Protein Structure 
Since the average pore size of the different glasses appears to have a definite 
impact on the protein leaching at elevated pH (section 3.6.2), the associated impact on 
protein folding was investigated. Comparison of the CD spectra of encapsulated WT 
SOD1 in the different glasses under various incubation conditions reveals that there is a 
definite impact in most cases except one, namely, with N(CH3)4-C1. As shown in Figures 
11, 15, and 17, corresponding to incubation in KOAc buffer at pH 5.7, pH 4.0, and in 
EDTA, respectively, the intermediate and final structural changes were different. In the 
case of N(CH3)4C1, it is suspected that the additional hydrophobic interactions 
predominate over the electrostatic forces (Jain and Ahluwalia, 1996) resulting in identical 
protein conformation. This will be discussed further in section 4.2. In the case of the 
xerogel, it was expected that the protein conformational change would be different than 
the wet sol-gel due to the smaller pore size. However, the data gathered in this case is 
considered unreliable due to the limited protein concentration used as discussed 
previously, and the resulting signal to noise ratio. On the other hand, the xerogel data 
could be viewed as a very rough estimate. With that in mind, the data show that there is a 
definite difference in protein structure when incubated in N(CH3)4C1 as compared with 
other buffers (section 3.6.4, Figure 33) regardless of the sol-gel method used for 
encapsulation. 
4.1.3 Effect of Water Confinement in the Silica Pores 
While there is certainly no shortage of theories and hypotheses regarding the 
critical role that water plays on protein folding, many of the physical properties of water 
itself remain elusive (Stanley et al., 2007). Nevertheless, recent experiments have 
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revealed an intriguing water property when confined in silica nanotubes made with 
MCM-41 with pore diameter of 15 ± 1 A (Liu et al, 2007, Stanley et al, 2007). Such 
confinement changed the water behavior significantly such that water remained in the 
liquid state when supercooled down to 160 K (-113°C). In other studies, different aspects 
of confinement on water structure and dynamics are discussed. Takamuku and 
colleagues (1997) showed various water structure and dynamic properties depending on 
water confinement in porous silica of two different pore sizes (30 and 100 A). 
Furthermore, the vibrational energy of confined water molecules in porous silica, with 
pore size of 90 A at ambient temperature, is proven to be lower than that of 
bulk/unconfined water (Hall et al., 1981). 
The observations above suggests that the loosely defined "bulk water" should not 
be assumed to possess the same properties as the "confined bulk water" within the silica 
pores, and that the properties of the confined water is also critically dependent on the 
level of confinement (i.e., water properties could be slightly different in pore sizes of 15, 
30, and 100 A). The relevance of these observations to this study is that the 
conformational changes noted in the previous section relating to pore sizes may not only 
be due to the obvious variable restriction on the rotational movement of the protein, but 
that the change in water properties in these pores is an important factor. The average 
pore size for the gel70 is assumed to be around 100 A (Eggers and Valentine, 2001a), but 
the reduction of the average pore size with sol-gel is unknown. However, considering 
the dimensions of the encapsulated SOD1, and considering that the encaging silica matrix 
around the protein does not form a perfect sphere, the amount of water entrapped 
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between the surface of the protein and the silica structure could be different even with a 
small change in the average pore size. 
In addition to the water structure factor, there are other important considerations 
resulting from encapsulation such as the electrostatic interaction between the protein and 
the silica matrix. In particular, under most test conditions the active site of SOD 1 is 
positively charged whereas the silica walls are negatively charged (pi around 2.5). This 
may not only be a factor after the encapsulation process is complete, but may play a role 
in the formation of the silica matrix around the protein. For instance, with the sol-gel70 
protocol, while the net charge of the protein is negative, the active site is still positive 
while other parts of the protein's surface are negatively charged. Hence the formation of 
the silica matrix around the protein may favor interaction with certain parts of the 
protein's surface but not others. This is illustrated in Figure 34 by calculating the 
electrostatic potential around the WT SOD1 at pH 7.0 using DeepView/Swiss-pdb 
Viewer V3.7. The protein's data used for the model was obtained from the Protein Data 
Bank (PDB, ID 2C9V). 
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Electrostatic field around the surface 
Legends: 
• : Active site 
Blue color: Positive charge at pH 7.0 
Red color: Negative charge at pH 7.0 
Figure 34. Electrostatic field around the SODldimer at pH 7.0. Calculations were done 
using DeepView/Swiss-pdb Viewer V3.7. Protein data was obtained from PDB, ID 
2C9V. 
4.1.4 The Effect of pH 8.0 on Leaching 
As discussed in section 3.6.2 in Figure 29, there was a significant increase in 
protein leaching when incubated in pH 8.0 as compared with pH 7.0 buffers. This was 
surprising since the encapsulated protein did not show a major change in the secondary 
structure, which could have easily been explained by the change in the net charge of the 
protein (i.e., more residues become solvent exposed). Furthermore, this observation was 
consistent with hSODl (WT and A4V) and bSODl using different sol-gel protocols. 
This increase in the net negative charge is obviously due to more residues on the protein 
becoming deprotonated with pH 8.0, but which residues was unclear. To address this, the 
t • * » . 
Classical strand view 
Surface charge 
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following two basic questions are considered: which residues are the potential suspects, 
and are these residues exposed, or partially exposed, to solvent in the native fold? 
First, all of the 153 amino acids per WT SOD1 subunit are listed, and the 
frequency of each is plotted as shown in Figure 35. Among these, the polar-charged 
basic or acidic residues are highlighted. The pK.Rof the side chains of both lysine and 
arginine are above 10, and are therefore always positively charged at pH 7.0 and 8.0. 
Aspartate and glutamate have PKR around 4, thus will be negatively charged in the above 
pH range. This leaves the amino acid residues histidine and cysteine as the major 
suspects with pK.R of 6.04 and 8.37, respectively. Using the Henderson-Hasselbach 
equation, the fraction of the His and Cys side chains carrying a positive charge vs. pH is 
plotted as shown in Figure 36. From the figure, 90% of His side chains are deprotonated 
at pH 7.0, and an addition 9% will be deprotonated at pH 8.0. Similarly, for Cys an 
additional 26% will be deprotonated at pH 8.0. However, this assumes that the His and 
Cys residues are solvent exposed and there are no interactions with other residues. As a 
result, the next step is to look at where the His and Cys residues are located on the protein 
and their states. 
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Glu Asp His Lys Arg Cys Asn Gin Pro Trp Ser Thr Gly Ala Phe Leu Val lie 
Figure 35. Plot of all the amino acids found in a WT SOD1 subunit. Polar acidic and 
basic amino acid residues are negatively and positively charged, respectively. The blue 
color indicates the positively charged amino acid residues, and the red color the 
negatively charged amino acid residues at pH 7.0. The percentage of each amino acid 
residue out of the 153-total is shown at the bottom. 
Figure 36. Fraction of histidine and cysteine side chains carrying a positive charge at 
different pH values. 
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Out of the eight His amino acids present per SOD1 subunit, six (His , His , 
His .His'SHis^andHis"") are involved in the copper and zinc metal binding site, and 
two are not (Goto et al., 2000). The remaining two are: His43, which is buried in the |3-
strand 4 and thus inaccessible, and His n o is solvent exposed as shown in Figure 37 
(PDB: 2C9V and MBT Protein Workshop were used to generate the views). In addition, 
out of the four Cys residues, two form the disulfide bond (Cys57 and Cys146), Cys6 is 
buried, while Cys111 is solvent exposed. As a result, in the fully metallated dimer, two 
His n o and two Cys111 residues could be deprotonated further at pH 8.0. However, it 
should be noted that this estimate does not take into account the pK shifts related to the 
folded protein. The protein's net charge under different pH values was estimated by 
using a public tool (http://www.scripps.edu/cgi-bin/cdputnam/protcalc3'), as shown in 
Appendix-A. Based on the output, the protein's net charges are estimated to be -4.2 and -
7.3 at pH 7.0 and 8.0, respectively. This difference may be significant enough to justify 
the major increase in protein leaching observed at pH 8.0 due to increased charge 
repulsion. 
94 
His110 
m\ 
His116 
Cys111, ., Cys
111 
Figure 37. Structural views of holo-WT SOD1 subunit showing the positions of the 
solvent exposed His110 and Cys111. (Figure from PDB, ID 2C9V, 180° rotation) 
4.2 N(CH3)4C1 Effect on Encapsulated SOD1 
The effect of N(CH3)4C1 on the secondary structure of entrapped SOD1 was found 
to be denaturing to the native conformation with one exception, namely, the xerogel 
encapsulation. This was surprising given that this salt has been shown in previous studies 
to produce a stabilizing influence on the structure of various proteins in aqueous solutions 
95 
(lysozyme) as well as proteins entrapped in sol-gel glass (apomyoglobin and serum 
albumin) (Jain and Ahluwalia, 1996; Eggers and Valentine, 2001a, 2001b). Since this 
apparent contradiction maybe due to several factors, a number of tests are compared 
below to determine the possible causes. Another intriguing observation was that the 
denatured structure for both the entrapped WT and A4V SOD1 appeared to be almost 
identical, which was a rare exception in this study. Furthermore, the conformation 
appeared to be a "stabilized" partial unfolding that was noticed with the WT SOD1 using 
different denaturing conditions. This will be discussed further at the end of this section, 
but first the apparent inconsistency with the studies listed above needs to be addressed. 
In this study, six different sol-gel samples were subjected to N(CH3)4C1 treatment 
as summarized in Table 2 below. The denaturation influence of N(CH3)4C1 was 
confirmed with all but the xerogel case, where the effect appeared to be stabilizing 
(Figure 33). Also it is important to note that the xerogel encapsulation process denatured 
the protein significantly, and in that case the addition of N(CH3)4C1 countered the 
denaturing influence of the silica matrix. Thus, this part is consistent with previous 
studies (Eggers and Valentine, 2001a, 2001b). However, with other sol-gel methods the 
encapsulation process did not denature the protein's native fold and the effect of 
N(CH3)4C1 in this case was denaturing. This destabilizing effect of N(CH3)4C1 was also 
observed in solution by Koga and co-workers (2006). These results suggest that the 
additional hydrophobic or electrostatic interactions introduced by the addition of 
N(CH3)4C1 are not necessarily always stabilizing (Jain and Ahluwalia, 1996). 
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Table 2. Summary of N(CH3)4C1 effect on SOD1 using different sol-gel preparation 
methods. 
Effect on 
entrapped 
WT-
hSOD1 
Effect on 
entrapped 
A4V-
hSOD1 
Effect on 
entrapped 
WT-
bSOD1 
Sol-gel preparation protocols 
sol-gel prepared 
with KOAc pH 
5.7 
(gel57) 
Destabilizing 
the initial native 
fold, but new 
conformation is 
stable. 
(Figure 26C) 
Destabilizing 
the initial native 
fold, but new 
conformation is 
stable 
(Figure 26H) 
not tested 
sol-gel prepared 
with KOAc pH 7.0 
(gel70) 
Destabilizing the 
initial native fold, 
but new 
conformation is 
stable 
(Figures 26F-F) 
not tested 
Destabilizing the 
initial native fold, 
but new 
conformation is 
stable 
(Figures 32C-C) 
10% Propyl 
modified glass 
not tested 
not tested 
Destabilizing 
the initial native 
fold, but new 
conformation is 
stable 
(Figures 32C-
C) 
Xerogel 
Stabilizing 
(Figure 33) 
not tested 
not tested 
In addition to the above, the different results observed with this and previous 
studies may involve other factors relating to the type of proteins used. For instance, by 
comparing the secondary structure of SOD1 with the two proteins used in previous 
studies, namely, apomyoglobin and serum albumin (Eggers and Valentine, 2001b), the 
following differences are revealed: a) both apomyoglobin and serum albumin proteins are 
mostly alpha helical (75% and 72% helical content, respectively); b) SOD1 proteins have 
a very small alpha helical content (only 7% helical, 39% beta sheets, and 54% random 
coil); and c) the percentage of hydrophobic residues on the surface of the proteins may be 
another factor that is relevant in this case. Furthermore, by comparing different older 
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studies (von Hippel and Wong, 1965; Jain and Ahluwalia, 1996) relating to the influence 
of N(CH3)4C1 on different proteins in solutions reveals that the results are not consistently 
stabilizing either. Based on Jain and Ahluwalia, (1996) the thermal denaturation stability 
(Tm) of Lysozyme protein in aqueous solutions varies depending on N(CH3)4C1 
concentration. At high concentration (5-6 M), N(CH3)4C1 demonstrates stabilizing 
influence on the protein's thermal stability, but at concentrations below 4 M N(CH3)4C1 
the opposite is true i.e., N(CH3)4C1 is indeed destabilizing. On the other hand, it was 
shown that the thermal stability of ribonuclease protein improves with N(CH3)4C1 
concentration of 0.5- 3 M (von Hippel and Wong, 1965). 
In summary, the effects of N(CH3)4C1, stabilizing or otherwise, are dependent on 
various factors including the protein type, N(CH3)4C1 concentration, initial folding state, 
and the crowding environment. 
4.3 The Effect of N(CH3)4C1, pH 4.0 and TCEP on the Secondary Structure of 
Encapsulated SOD1 
The effects of N(CH3)4C1 on the entrapped SOD1 (WT and A4V) were found to 
be remarkably similar even when the encapsulation processes were different i.e., using 
sol-gel70 and sol-gel5'7. As mentioned previously, it is suspected that the additional 
hydrophobic interactions and/or the influence of N(CH3)4C1 on the bulk water 
predominate over the pore size difference in this case. Intriguingly, the conformational 
changes for both the entrapped WT and A4V proteins appeared to be in a "suspended" 
partially unfolded state even after 54 days of incubation. In other words, the unfolding of 
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the encapsulated proteins was somehow halted, and the resulting denatured state was 
stable. Thus the key points that this section will focus on are what stabilized the protein 
in this state, and is there a different path to this state. 
First, the CD spectra of this "suspended" partially unfolded state (i.e., N(CH3)4C1 
measurements) are compared with other test data, and several conditions shown in Figure 
38A appeared to produce similar CD spectra after normalization. The first comparison 
shows the CD spectrum of encapsulated WT-hSODl when incubated in pH 4.0 at 4°C for 
54 days (Figure 15C), and the second is that of encapsulated A4V SOD1 under similar 
conditions but after only 2 days (Figure 16A). While the encapsulated WT SOD1 was 
stable after 54 days, A4V SOD1 under identical conditions continued to a complete and 
irreversible unfolding (Figure 16C). Furthermore, the encapsulated WT SOD1 sample 
described in section 3.2.2 (Figure 12G) appeared to refold to this "suspended" state even 
after being exposed to various buffers over 110 days. Finally, similar conformational 
changes were observed with EDTA (Figures 171 and 18C) implying metal loss. 
The above mentioned confirmations, at least in the 225-235 nm region, appeared 
also to be somewhat similar to the CD spectra of encapsulated WT-hSODl intermediate 
on the way to complete unfolding after TCEP treatment at 37°C (Figure 20D) after 
normalizing. Because this implied a potential reduction of the disulfide bond, the two 
samples that were previously incubated in the N(CH3)4C1 and KOAc (pH 4.0) were 
incubated afterwards in 40mM TCEP buffer for one day. The results demonstrated a 
slight structural change in the 225-235 nm and 200-208 nm regions (Figure 38B). Thus 
in order to determine if this minor difference was indeed due to a slight structural change 
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and in order to rule out potential measurement errors, the effects of TCEP and DTT on 
WT SOD1 in solutions were compared with the CD spectra of encapsulated proteins. The 
effect of TCEP on WT SOD1 in solution was investigated as part of this study, but the 
effect of DTT in solution was based on a previous study (Fujiwara et al., 2005) as shown 
in Figure 38C. The results were consistent, confirming that both TCEP and DTT had a 
slightly different impact on the protein's secondary structure as compared with the effects 
of N(CH3)4C1 and KOAc at pH 4.0. 
200 210 220 230 240 250 200 210 220 230 240 250 200 210 220 230 240 250 
Wavelength (nm) Wavelength (nm) Wavelength (nm) 
Figure 38. CD spectra of "suspended" partial unfolding for WT and A4V SOD1 under 
different conditions. (A). The first WT sample was incubated in TMAC1 for 54 days at 
4°C, the second sample in pH 4.0 for 54 days at 4°C, and the third sample was 
incubated in TCEP for 1 day at 37°C. The first A4V sample was incubated in TMAC1 
for 2 days at 4°C, the second sample in pH 4.0 for 2 days at 4°C, and the third sample in 
TCEP for 2 days at 4°C. (B). WT sample was incubated in TMAC1 for 54 days, then 
washed and replaced with TCEP. Another WT sample was incubated in pH 4.0 for 54 
days, then washed and replaced with TCEP. (C). The first WT incubated in TCEP after 
TMAC1, the second WT sample was equilibrated in TCEP after incubation in pH 4.0, 
the third WT sample in solution incubated in TCEP, and last WT sample incubated in 
DTT in solution taken from Fujiwara et al., 2005. 
From the above, it is clear that the disulfide bond was being impacted by 
incubation in either N(CH3)4C1 or KOAc pH 4.0 buffers, given that the change in the 
region between 225-235 nm was typically associated with the disulfides (Sreerama and 
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Woody, 2004). Metal loss was another possibility given the similarity with the EDTA 
CD spectra. However, this raises two more questions: 1) Why is there a difference in the 
225-235 nm spectra in the TCEP test as compared with the N(CH3)4C1 and pH 4.0 tests? 
2) Because the encapsulated WT proteins completely unfolded under the influence of 
either TCEP or EDTA and similar complete unfolding was observed in solution, what 
stabilized the unfolding process? 
One hypothesis was the formation of a non-native intramolecular disulfide bond 
involving Cys andCys n . This would not only stop the unfolding and stabilize the 
intermediate as observed but would also produce a slight difference in the CD spectra in 
the 225-235 nm region. In a recent study, Wang et al., (2006) suggested such a 
possibility as quoted below: 
Although we focus discussion on intermolecular disulfide bonds, it is important 
to note that non-native intramolecular bonds could also occur, that is bonds 
involving Cys residues other than the native bond between C57 and C146, and 
that such bonds could stabilize non-native conformations. Hence, non-native 
disulfide bonding could play a role in both misfolding of the monomer and 
stabilization of multimers. 
There was evidence of such scrambling of disulfide linkage involving Cys111 (non-
native) and Cys146 (native) that was noticed with apo-SODl in vitro after an extended 
storage period at 4°C (Di Noto et al., 2005). In addition, other recent studies also 
implicated Cys n in the formation of intermolecular disulfide cross-linking leading to 
aggregation (Banci et al., 2007; Cozzolino et al., 2008). The creation of intermolecular 
disulfide links with the sol-gel-entrapped proteins is very unlikely due to the silica 
matrix. However, the structural changes that lead to the formation of intermolecular 
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bonds in solution could also produce non-native intramolecular disulfide bonds in the 
encapsulated environment. This hypothesis, of course, requires further validation, 
perhaps by repeating the experiment and doing additional testing in the near UV in the 
CD to obtain information regarding the tertiary structure and the disulfide bond. While 
other explanations for the above "suspended", partially unfolded intermediate are 
possible, the non-native disulfide bond hypothesis is the most plausible candidate. 
4.4 Effects of TFE and Methanol on Encapsulated SOD1 
Before discussing the effects of alcohols used in this research, it is important to 
note that the A4V samples were previously incubated and tested in the various conditions 
listed in section 3.5 Figure 25. Thus the results observed could reflect the additive effects 
of multiple solution exchanges. 
As observed in section 3.5, low TFE concentration increased the helical content in 
the WT as well as A4V SOD1 secondary structure. When the TFE concentration and 
temperature were increased to 80% and 37°C, the WT protein unfolded. On the other 
hand, when 80% methanol at 37°C was added to the partially unfolded WT protein, a 
recovery of the secondary structure was detected. Under the same conditions, the 
partially unfolded, reduced A4V protein exhibited a new secondary structure with an 
intense minimum at around 212 nm (as compared to 208 nm), and the absence of the 
peak in the region of 225-235 nm. These data raise an interesting question: Why did the 
SOD1 behave differently under the effects of these alcohols? 
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One possible answer is based on the physiochemical properties of the alcohols 
and their acidity compared to water. TFE with a pKa of 12.4 was more acidic than water 
(pKa of 15.7). From infrared and NMR spectroscopies, it was found that the increased 
acidity could decrease the fraction of water molecules with nonbonded lone pairs 
(Symons, 1981). Therefore, the increased acidity of TFE made water "less hydrogen-
bond competent" (Kentsis and Sosnick, 1998). As a result, the occurrence of hydrogen 
bonding between amides and carbonyl moieties on the SOD1 and TFE was probably 
diminished, and that could lead to desolvation of the protein. On the other hand, 
methanol with a pKa of 15.0 was less acidic than TFE, and at high concentration had the 
opposite effect to TFE; it allowed WT protein to refold to the native conformation most 
likely due to the strong intramolecular hydrogen bonds in the protein main chain. 
Recently, it was observed that at high methanol concentration of 80%, as the hydrogen 
bonds between the protein and the solvent became weaker, the intramolecular hydrogen 
bonds in the protein main chain became stronger (Yamazaki et al., 2006). So the solvent 
acidity could change the properties of water, which in turn influence hydrogen bond 
formation and indirectly the hydrophobic interactions. 
4.5 Metallation State of Encapsulated SOD1 
Determining the metallation state of the encapsulated proteins purely based on the 
far-UV CD spectra proved to be more challenging than initially thought. This was 
primarily due to the fact that the CD region of interest (i.e., below 210 nm) was rather 
noisy as shown in this study as well as in a previous work on SOD1 in solution (Fujiwara 
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et al., 2005). Despite this, when the encapsulated protein was incubated for longer 
periods, certain trends were clear and the CD signal became less noisy over time. The 
CD spectra for the encapsulated apo-WT SOD1 and holo-WT SOD1 were in agreement 
with the spectra obtained in solution (Arnesano et al., 2004; Potter et al., 2007). The 
major difference, however, was that the remetallation of the entrapped apo-WT SOD1 in 
sol-gel matrices was not always successful depending on various factors, whereas the 
entrapped apo-A4V SOD1 could not be remetallated at all. In the following, the 
experiment in which apo-WT SOD1 could not be remetallated is discussed first, followed 
by the successful case. 
When incubated in EDTA for 54 days, the encapsulated WT SOD1 showed two 
conformational changes (Figures 17D-F). In the first seven to nine days, the 
conformational changes appeared to be very similar to the solution study (Potter et al., 
2007). However, after a total of 54 days of incubation in EDTA, a new conformational 
change was observed that resembled the aforementioned "suspended" partial unfolding 
state. After forming this conformation, remetallating the entrapped protein was not 
9-1-
possible, even though in solution studies it had been shown that both metals, Zn and 
Cu2+, could be added to the apoprotein (DiDonato et al., 2003; Potter et al., 2004). It was 
known that, upon metal loss, structural changes took place in the apoprotein; both the 
zinc and the electrostatic loops became highly disordered, and the zinc-binding site 
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became solvent exposed. Yet, in this configuration the Zn could still be added to the 
binding site (Banci et al., 2003). It was suspected, therefore, that the metal binding site 
of the entrapped protein was affected by the final conformation. Based on the CD spectra 
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shown in Figures 17F-I, the dip in the 225-235 ran region was also indicative of disulfide 
bond modification as discussed in the previous section. Thus the long-term incubation in 
EDTA (i.e., 54 days) was suspected to induce not only metal loss in the first seven to nine 
days (Figure 17E), but also disulfide modification thereafter (Figure 17F). One possible 
explanation for this was that after the metal loss, the intra-subunit disulfide bonds were 
reduced resulting in two entrapped monomers, which then recombined to form the non-
native intramolecular disulfide bond. Under similar conditions in solution studies (i.e., 
when both metal loss and disulfide reduction occurred), the resulting monomers were 
shown to create intermolecular disulfide bonds (Band et al., 2007). However, as 
mentioned in the previous section, the entrapped monomers were prevented by the silica 
matrix from forming intermolecular disulfide bonds, thus the formation of non-native 
intramolecular disulfide bonds was the most probable option. This could be an important 
finding for future studies since the remetallation of this species was not possible, and that 
could lead to loss of the enzymatic activity (i.e., due to permanent metal loss) as well as 
the possibility of an early step in the aggregation pathway. 
On the other hand, remetallating encapsulated WT SOD1 was possible under 
different incubation conditions. After incubating WT SOD1 in KOAc buffer at pH 5.7 
for 54 days, the observed final conformational change was again similar to the apo-WT 
protein obtained in solution (Potter et al., 2007), and almost identical to the initial 
conformation noticed with EDTA (i.e., 7-9 days) as shown by comparing Figure 1 IF with 
Figure 17E. It is important to note that wet sol-gel7 ° was used for both of the samples 
used in the previous EDTA experiment and in the one shown in Figure 1 IF. Thus the 
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sol-gel pore size or the encapsulation process variation was eliminated as a variable in 
this comparison. It was not clear why the protein lost the metal in this case but based on 
the CD spectrum, the data certainly implied that possibility. In order to confirm this, 
Zn2+ was added to the same sample, and the structural changes observed in Figure 12B 
(200-208 nm) were found to be similar to those observed with solution study for holo-
WT and apo-WT respectively. The conclusion derived from this experiment is that 
remetallation of encapsulated apo-WT in sol-gel is possible, and that the failure of 
remetallation in the previous test with EDTA is not due to the sol-gel encapsulation but 
the structural changes to the protein. 
4.6 WT-SOD1: Possible Intermediates or Artifacts 
Out of the 660 CD measurements taken in this study, eight measurements showed 
abnormal CD spectra that were difficult to reproduce. These measurements were initially 
believed to be due to test errors or equipment glitches and thus discarded. However, later 
analysis revealed non-random patterns that could be due to a possible intermediate or an 
artifact. The observed secondary structure changes in these measurements were all red 
shifted with respect to the native fold, and the extent of the red shift seemed to correlate 
to the sol-gel process used for encapsulating the proteins as shown in Figures 39 and 40. 
With the sol-gel5 7 process, the CD minimum was consistently shifted from 208 to around 
215 nm, whereas with the sol-gel process the minimum was shifted to around 212 nm. 
These red shifts were observed only with the entrapped human and bovine WT-SOD1, 
but not with the entrapped A4V-SOD1. Considering the number of CD measurements 
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taken during this study (i.e., 180 for A4V, 450 for WT, and about 30 for the bovine 
SOD1), it was highly unlikely that these measurements represented random artifacts. In 
addition, the fact that these anomalous measurements were taken from five different sol-
gel batches and that the extent of the red-shift correlated with sol-gel preparation method 
reinforced the possible link to the sol-gel process. However, whether these 
measurements represented possible ephemeral intermediates or artifacts related to the sol-
gel process were difficult to determine. To address this, one of the CD measurements 
was repeated immediately after noticing the red shift (Figures 40F-F'). In this case the 
sample was left in the CD equipment and the measurement was repeated, within five 
minutes, without any modifications to the test conditions. As shown in the figure, the 
second measurement appeared to be native-like after normalization as compared with the 
first. While this strongly suggested the possibility of a sol-gel related artifact, the 
possibility of an ephemeral protein intermediate sol-gel related artifact could not be 
precluded since these experiments were not repeated due to the limited protein/glass 
samples. Glass sample-related artifacts may arise from a rough or inhomogeneous glass 
surface facing the light source of the CD spectrometer. 
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Figure 39. CD spectra of possible transient intermediates or artifacts with sol-gel5'7. (A-
B) Same as Figures 11A-B, human WT-SOD1, encapsulated in sol-gel57, batch#l. (C-
D) Same as Figures 13A-B, sol-gel sample reused. (E-F) Same as Figures 17A-B, 
different sample is used from the same batch as above. (G-H) Same as Figures 21G-H, 
different sample used from the different batch. 
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Figure 40. CD spectra of SOD 1 as possible transient intermediates or artifacts with 
different sol-gel methods. (A-B) Same as Figures 31F, F'. (C-D) Same as Figures 311, F. 
(E-F) Same as Figures 26D-E'. (G-H) Same as Figures 10A, B. B', D', E', and F' are 
normalized spectra of B, D, E, and F, respectively. 
4.7 Concluding Remarks 
In conclusion, SOD1 entrapment in wet-aged sol-gel is proven to be a viable 
approach to obtain unique data that is not possible with solution tests in many cases. It is 
hoped that future investigations relating to SOD1 conformational changes will find the 
above data useful. The sol-gel encapsulation could be extended to other 
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neurodegenerative disorders where aggregation is an issue such as Alzheimer's, 
Parkinson's, Huntington's and prion diseases. 
Important findings were as follows. 
1. Sol-gel encapsulation 
• The pH used during the encapsulation process affected the sol-gel pore size, 
protein leaching, and protein conformations. 
2. Wt protein 
• The salt N(CH3)4C1 caused the protein to adopt a stable partially unfolded 
secondary structure under near physiological conditions (i.e., pH 7.0 and 
crowding). Similar structural changes were also observed under two other 
conditions (i.e., pH 4.0 and in TCEP/DTT). 
• After 54 days of incubation in KOAc, pH 5.7, loss of Zn ion occurred in the 
absence of a metal chelator. 
• The uptake of the Zn 2+ ion by the apo-WT SOD1 was not always possible. 
3. A4V protein 
• The secondary structure of the encapsulated A4V SOD1 exhibited a common 
increase in negative ellipticity in the region between 225 and 240 nm of the CD 
spectrum under the following aggregation conditions: KOAc, pH 5.7, EDTA, 
and TCEP/DTT. 
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Future studies to be considered. 
• Testing the encapsulated WT protein using various salts (i.e., other than 
N(CH3)4C1) to determine if some of the salts that are abundant in human cells 
can cause the aforementioned stable partial unfolding. 
• Further analysis of the stable partial unfolding state using a different testing 
method than CD such as the fluorescent quenching technique, to study 
modifications in protein conformation. 
I l l 
Appendix A: Protein Charge 
Tool used to estimate protein charge at different pH values. 
http://www.scripps.edu/cgi-bin/cdputnam/protcalc3; 
PDB: 2c9v sequence used for input. 
PROTEIN CALCULATOR v3.3 
Accepted Sequence 
ATKVVCVLKG DGPVQGIINF EQKESNGPVK VWGSIKGLTE GLHGFHVHEF 
GDNTAGCTSA 60 
GPHFNPLSRK HGGPKDEERH VGDLGNVTAD KDGVADVSIE DSVISLSGDH 
CIIGRTLVVH 120 
EKADDLGKGG NEESTKTGNA GSRLACGVIG IAQ 153 
Estimated charge at pH 7.00 = -4.2 
WARNING: pi estimate assumes all residues have pKa values that are equivalent to the 
isolated residues. For a folded protein this is not valid. However, this rough value can be 
useful for planning protein purifications. pKa values for the individual amino acids from 
Stryer Biochemistry, 3rd edition. 
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Estimated charge over pH range 
PH 
4.00 
4.50 
5.00 
5.50 
6.00 
6.50 
Hi 
7.50 
SI 
8.50 
9.00 
9.50 
10.00 
Charge 
17.1 
11.3 
6.0 
2.8 
0.6 
-1.9 
M 
-5.9 
91 
-9.0 
-10.9 
-13.3 
-16.4 
Both pH 7 and pH 8 are highlighted in green to show the estimated protein net 
charge, which is relevant to section 4.1.4. 
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